WO2010027693A2 - Method and system for sealing percutaneous punctures - Google Patents
Method and system for sealing percutaneous punctures Download PDFInfo
- Publication number
- WO2010027693A2 WO2010027693A2 PCT/US2009/054492 US2009054492W WO2010027693A2 WO 2010027693 A2 WO2010027693 A2 WO 2010027693A2 US 2009054492 W US2009054492 W US 2009054492W WO 2010027693 A2 WO2010027693 A2 WO 2010027693A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sealing material
- sealing
- component
- delivery tube
- tip
- Prior art date
Links
- 238000007789 sealing Methods 0.000 title claims abstract description 226
- 238000000034 method Methods 0.000 title claims description 110
- 239000003566 sealing material Substances 0.000 claims abstract description 301
- 230000008878 coupling Effects 0.000 claims description 74
- 238000010168 coupling process Methods 0.000 claims description 74
- 238000005859 coupling reaction Methods 0.000 claims description 74
- 230000007246 mechanism Effects 0.000 claims description 35
- 239000000463 material Substances 0.000 claims description 34
- 239000012530 fluid Substances 0.000 claims description 14
- 230000006835 compression Effects 0.000 claims description 11
- 238000007906 compression Methods 0.000 claims description 11
- 229920000642 polymer Polymers 0.000 claims description 6
- 210000004204 blood vessel Anatomy 0.000 description 65
- 239000007788 liquid Substances 0.000 description 16
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 230000008901 benefit Effects 0.000 description 10
- 238000001356 surgical procedure Methods 0.000 description 7
- 238000000926 separation method Methods 0.000 description 5
- 239000007799 cork Substances 0.000 description 4
- 239000011343 solid material Substances 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 238000002399 angioplasty Methods 0.000 description 3
- 230000009969 flowable effect Effects 0.000 description 3
- 239000011796 hollow space material Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 238000002583 angiography Methods 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 210000001105 femoral artery Anatomy 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- 238000002357 laparoscopic surgery Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000227 bioadhesive Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- -1 e.g. Substances 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00491—Surgical glue applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00491—Surgical glue applicators
- A61B2017/00495—Surgical glue applicators for two-component glue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00535—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated
- A61B2017/00557—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/0065—Type of implements the implement being an adhesive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/00654—Type of implements entirely comprised between the two sides of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00672—Locating means therefor, e.g. bleed back lumen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00778—Operations on blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00982—General structural features
- A61B2017/00991—Telescopic means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/03—Automatic limiting or abutting means, e.g. for safety
- A61B2090/037—Automatic limiting or abutting means, e.g. for safety with a frangible part, e.g. by reduced diameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
- A61B2090/064—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
Definitions
- the present disclosure relates generally to a method and system for sealing, and more particularly, to a method and system for sealing percutaneous punctures.
- the invention relates generally to the sealing of punctures for various medical procedures and more particularly to the sealing of such punctures using, in certain embodiments, a multi-stage sealing material ejected into the puncture.
- Certain medical procedures require the percutaneous puncturing of the body tissue of a patient to gain access to a cavity in the body to perform a medical procedure.
- a procedure is the puncturing of body tissue and a blood vessel wall to gain access to the interior of the vascular system of the patient.
- Such procedures that commonly require the percutaneous puncturing of a blood vessel wall are balloon angioplasty procedures, arteriography, venography, angiography and other diagnostic procedures that use blood vessel catheterization.
- Examples of other procedures requiring a puncture through body tissue into a cavity include laparoscopic surgery and other microscopic surgery techniques using a small incision.
- the present disclosure is directed to a device for sealing a puncture in a patient.
- the device includes a sealing component including an elongate control member configured to pass through a puncture in skin of a patient.
- the sealing component also includes an expandable member disposed near a distal end of the elongate control member, and a tip releasably attached to the elongate control member distal to the expandable member.
- the device also includes a sealing material delivery component including a delivery tube through which the elongate control member of the sealing component is configured to extend. The delivery tube is configured to deliver sealing material through an opening in a distal end of the delivery tube.
- the present disclosure is directed to a method of sealing a puncture in a wall of a body cavity of a patient.
- the method includes inserting a sealing component and a sealing material delivery component through a puncture in a wall of a body cavity of a patient.
- the sealing material delivery component includes a delivery tube, and the sealing component is slidably disposed in the delivery tube and includes an elongate control member.
- the method also includes inserting an expandable member connected to the elongate control member through the puncture into the body cavity, expanding the expandable member when the expandable member is distal to a distal end of the delivery tube and inserted in the body cavity, and moving the expandable member near a distal surface of the wall of the body cavity.
- the method further includes delivering a first sealing material through the distal end of the delivery tube and into the puncture, withdrawing the elongate control member from the patient, and delivering a second sealing material proximal to the wall of the body cavity after the elongate control member is withdrawn from the patient.
- the present disclosure is directed to a method of sealing a puncture in a wall of a body cavity of a patient.
- the method includes inserting a sealing component and a sealing material delivery component through a puncture in a wall of a body cavity of a patient.
- the sealing material delivery component includes a delivery tube, and the sealing component is slidably disposed in the delivery tube and includes an elongate control member.
- the method also includes inserting an expandable member connected to the elongate control member through the puncture into the body cavity, expanding the expandable member when the expandable member is distal to a distal end of the delivery tube and inserted in the body cavity, and moving the expandable member near a distal surface of the wall of the body cavity.
- the method further includes delivering sealing material through the distal end of the delivery tube and into the puncture, inserting a tip disposed on the elongate control member and distal to the expandable member into the sealing material, and detaching the tip from the elongate control member when the tip is in the sealing material.
- the present disclosure is directed to a method of sealing a puncture in a wall of a body cavity of a patient.
- the method includes inserting a sealing component and a sealing material delivery component through a puncture in a wall of a body cavity of a patient.
- the sealing material delivery component includes a delivery tube, and the sealing component is slidably disposed in the delivery tube and includes an elongate control member.
- the method also includes inserting an expandable member on the elongate control member through the puncture into the body cavity, and expanding the expandable member when the expandable member is distal to a distal end of the delivery tube and inserted in the body cavity.
- the method further includes locating the wall of the body cavity by retracting the sealing component with respect to the patient until the expandable member in the expanded configuration abuts a distal surface of the wall of the body cavity, and delivering sealing material through the distal end of the delivery tube and proximal to the wall of the body cavity.
- the present disclosure is directed to a sealing component for sealing a puncture in a patient.
- the sealing component includes an elongate control member configured to pass through a puncture in skin of a patient, an expandable member disposed near a distal end of the elongate control member, and a tip releasably attached to the elongate control member distal to the expandable member.
- the present disclosure is directed to a method of sealing a puncture in a wall of a body cavity of a patient.
- the method includes inserting a sealing component and a sealing material delivery component through a puncture in a wall of a body cavity of a patient.
- the sealing material delivery component includes a delivery tube, and the sealing component is slidably disposed in the delivery tube and includes an elongate control member.
- the method also includes inserting an expandable member releasably connected to the elongate control member through the puncture into the body cavity, expanding the expandable member when the expandable member is distal to a distal end of the delivery tube and inserted in the body cavity, and moving the expandable member near a distal surface of the wall of the body cavity.
- the method further includes delivering a sealing material through the distal end of the delivery tube and into the puncture, collapsing the expandable member, and inserting the collapsed expandable member in a cavity formed in the sealing material.
- the method also includes expanding the expandable member in the cavity formed in the sealing material and detaching the expandable member in the expanded configuration from the elongate control member when the expandable member is in the sealing material.
- Figure 1 is a side view of an exemplary embodiment showing a delivery component.
- Figure 2 is a side view of an exemplary embodiment showing a temporary sealing component.
- Figure 3 illustrates an exemplary embodiment with the sealing system assembled and inserted into a guide sheath protruding from a blood vessel.
- Figure 4 illustrates an exemplary embodiment with the guide sheath and the assembled sealing system in a retracted position.
- Figure 5 illustrates an exemplary embodiment with the sealing system delivering the first stage of sealing material into the puncture.
- Figure 6 illustrates an exemplary embodiment with the temporary sealing component being removed from the assembled sealing system.
- Figure 7 illustrates an exemplary embodiment with the delivery component delivering the second stage of sealing material into the puncture.
- Figure 8 illustrates an exemplary embodiment with the guide sheath remaining in tract during closure with sealing system inserted.
- Figure 9 illustrates an exemplary embodiment with the guide sheath up against tamponading member.
- Figure 10 illustrates an exemplary embodiment with guide sheath retracted back from tamponading member.
- Figure 11 illustrates an exemplary embodiment with sealing system retracted at a known tension and skin securement hub attached to the guide sheath.
- Figure 12 illustrates an exemplary embodiment with skin securement hub attached to a delivery tube.
- Figure 13 illustrates an exemplary embodiment with a delivery tube retracted prior to delivery of a second stage of sealing material.
- Figure 14 illustrates an exemplary embodiment delivering the second stage sealing material through the guide sheath.
- Figure 15 illustrates an exemplary embodiment with an expandable member attached to a delivery tube and positioned within body tissue.
- Figure 16 illustrates an exemplary embodiment with an expandable member attached to a delivery tube and positioned within the guide sheath.
- Figure 17 illustrates an exemplary embodiment of a sealing system delivering first stage sealing material to create a hollow cavity for positioning a tip.
- Figure 18 illustrates an exemplary embodiment of a hollow cavity created by a sealing system after first stage sealing material is delivered.
- Figure 19 illustrates an exemplary embodiment of a tip and second stage sealing material positioned within a hollow cavity.
- Figure 20 illustrates an exemplary embodiment of a tip with barbs secured to the sides of a body.
- Figure 21 illustrates an exemplary embodiment of a tip with rings around a body.
- Figure 22 illustrates an exemplary embodiment of a tip with independent rings around a body.
- Figure 23 illustrates an exemplary embodiment of a tip that is expandable.
- Figure 24 illustrates an exemplary embodiment of a tip constructed of a suture with a knot tied within a main body of the suture.
- Figure 25 illustrates an exemplary embodiment of a tip constructed of a suture with a knot tied within the main body with a disc.
- Figure 26 illustrates an exemplary embodiment of a tip constructed of a braid configuration.
- Figure 27 illustrates an exemplary embodiment of a tip constructed of a semi-rigid body with a soft pliable end.
- Figure 28 illustrates an exemplary embodiment of a tip positioned within first stage sealing material and second stage sealing material.
- Figure 29 illustrates an exemplary embodiment of a tip positioned within first stage sealing material.
- Figure 30 illustrates an exemplary embodiment of a tip positioned in close proximity to a blood vessel wall.
- Figure 31 illustrates an exemplary embodiment of a tip in contact with first stage sealing material and second stage sealing material.
- Figures 32-35 illustrate various exemplary embodiments of mechanisms for releasably attaching a tip to a temporary sealing component.
- the systems disclosed herein can be used to close or seal percutaneous punctures made through the body tissue of a patient to gain access to a body cavity of a patient. Access through these percutaneous punctures allows a physician to carry out various procedures in or through the body cavity for examination, surgery, treatment and the like. While not meant to be limiting, the systems are illustrated being used to seal the percutaneous punctures made to gain access to blood vessels in patients for various procedures. It will be appreciated that the systems are applicable to other procedures requiring sealing of a puncture through body tissue into a cavity including laparoscopic surgery and other microscopic surgery techniques using a small incision.
- proximal and distal are used herein to refer to the relative positions of the components of the exemplary sealing system 10.
- proximal refers to a position relatively closer to the exterior of the body or closer to the surgeon using the sealing system 10.
- distal refers to a position relatively further away from the surgeon using the sealing system 10 or closer to the interior of the body.
- sealing system 10 is illustrated being used to seal a percutaneous puncture PP seen in FIG. 3 made through the skin SK, body tissue BT and the wall BVW of a blood vessel BV as an incident to a medical procedure.
- the blood vessel BV used is a femoral artery in the groin region with a relatively large vessel passage or lumen BVL to facilitate locating the blood vessel BV and permitting a sufficiently large puncture to be made through the wall BVW thereof to carry out the procedure.
- Medical procedures which are typically performed through such a puncture are angioplasty and other procedures which pass a catheter or other type of probe into and along the blood vessel lumen BVL.
- an initial percutaneous puncture PP with an appropriate needle is made from the patient's skin SK through the tissue BT and the blood vessel wall BVW into the blood vessel lumen BVL, and a guide wire is installed.
- the needle is then removed leaving the guide wire in place and a tapered introducer guide sheath GS is installed over the guide wire to enlarge the puncture so as to permit easier access to the blood vessel BV.
- the guide sheath GS serves to keep the passage open and prevent further damage to the tissue BT and skin SK around the passage during the medical procedure.
- the guide sheath GS while not required to be used in connection with the present invention, assists in the installation of the sealing system 10 as will become more apparent.
- FIG. 1 an exemplary embodiment of the sealing system 10 is illustrated showing a temporary sealing component 1 1 and a sealing material delivery component 12.
- the connector 14 permits positioning of the temporary sealing component 11 relative to the sealing material delivery component 12 in one or more defined positions relative to each other and allows one to positively locate the temporary sealing component 11 and the sealing material delivery component 12 when inserted into the puncture PP.
- the temporary sealing component 11 typically may be pre-assembled within the sealing material delivery component 12 during manufacture, creating the sealing system 10.
- the sealing system 10 is inserted into the blood vessel lumen BVL through the introducer guide sheath GS as seen in Figure 3.
- an expandable tamponading member 21 of temporary sealing component 1 1 is expanded.
- the sealing system 10 and sheath GS are then retracted, and the expandable tamponading member 21 of temporary sealing component 1 1 serves to temporarily seal the interior end of the puncture PP opening into the blood vessel lumen BVL.
- the sealing material delivery component 12 is located in the puncture PP and proximate to the punctured blood vessel wall BVW, as seen in Figure 4.
- the first stage 67 of the sealing material for sealing the puncture PP is injected through the sealing material delivery component 12 as seen in Figure 5 and as described in greater detail below.
- the expandable tamponading member 21 is contracted and temporary sealing component 11 is removed, leaving a bioabsorbable tip 23 behind as seen in Figure 6.
- a second stage 68 of sealing material is then installed in the puncture PP as the sealing material delivery arrangement 12 is removed as seen in Figure 7.
- the exemplary embodiment of the sealing material delivery component 12 comprises a distal end 64, a delivery tube 60, a first coupling 63, and a first sealing material port 65.
- the distal end 64 is the opening through which the first and second stage sealing materials 67, 68 are deposited into the puncture PP.
- the delivery tube 60 may be manufactured from any number of materials without departing from the scope of the invention.
- the delivery tube 60 is made of a polymeric material such as high-density polyethylene (HDPE) or polyamide.
- Figure 1 also illustrates an exemplary cross section of delivery tube 60 showing a double-barrel tube with cavities 31 and 32.
- the shape of cavities 31 and 32 can take a variety of forms.
- Cavity 31 is the cavity through which the sealing material (first stage 67 and/or second stage 68) passes on its way to exiting at the distal end 64 and being deposited in the puncture PP. In alternate embodiments of the invention, cavity 31 may be divided into two or more cavities, where a different stage 67, 68 of sealing material passes through each distinct cavity.
- Cavity 32 is the space through which the temporary sealing component 11 passes when the sealing system 10 is assembled. Cavity 32 also may be used for delivery of sealing material, and particularly second stage sealing material 68, when temporary sealing component 11 is removed from cavity 32.
- the sealing material used in the first and second stages 67, 68 of sealing the puncture PP may be any of a number of different biocompatible materials as long as the material has the capability of maintaining a seal in the puncture PP.
- the sealing material could be a liquid or gel that is flowable.
- the sealing material can be a combination of liquid and solid materials, for example, the first stage sealing material 67 could be a preformed solid and the second stage sealing material 68 could be a flowable material.
- the sealing material can be a compound that is mixed either prior to inserting the sealing material into the sealing material delivery component 12 or that is mixed as it passes through the sealing material delivery component 12.
- the sealing material may be a material that actually bonds the body tissue BT at the puncture PP together such as a biocompatible adhesive.
- the sealing material is a polyethylene glycol based adhesive in a flowable state.
- the exemplary temporary sealing component 11 illustrated in Figure 2 fits within cavity 32 of sealing material delivery component 12 so that the two components can be assembled into the sealing system 10.
- the temporary sealing component 11 includes an elongate flexible control member 20. Proximate to the distal end of the control member 20 is mounted an expandable tamponading member 21. In addition to serving a tamponading function, expandable member 21 also provides a locating function as described in connection with Figure 4 below.
- the control member 20 is configured so that the distal end 22 and bioabsorbable tip 23 may pass through the guide sheath GS into the blood vessel lumen BVL.
- the proximal end 24 of member 20 connects with a second coupling 25 which includes an expansion mechanism.
- the expansion mechanism controls the expansion and contraction of the expandable tamponading member 21.
- the expansion mechanism may take a variety of forms including a tube for delivery of an expansion gas or liquid or springs, couplings or other mechanical or electromechanical components for adjusting the size of the expandable tamponading member 21.
- second coupling 25 includes a port or valve 28 for connection to a syringe 26.
- the port 28 is connected to the proximal end 24 of control member 20 and allows a gas or liquid from the syringe 26 to expand and contract the expandable tamponading member 21.
- the expandable tamponading member 21 In its collapsed condition, the expandable tamponading member 21 closely adheres to the outside surface of control member 20. In its expanded condition, the expandable tamponading member 21 is large enough to seal the puncture PP in the body cavity as illustrated in Figure 4 and as described further below.
- Second coupling 25 also includes a connector 14 to fix the position of the temporary sealing component 11 to first coupling 63 of the sealing material delivery component 12.
- the connector 14 is illustrated as a threaded member in the exemplary embodiment shown in Figure 2.
- connector 14 can take a variety of forms and may be attached to first coupling 63 through a variety of attaching mechanisms including springs, clips and various recesses or protrusions.
- the exemplary embodiment shown in Figure 2 also illustrates a cross section of control member 20 showing inflation lumen 30 and wire 27.
- the inflation lumen 30 is the cavity through which the liquid or gas passes to expand and contract the expandable tamponading member 21.
- the wire 27 connects second coupling 25 to the proximal end of bioabsorbable tip 23.
- the bioabsorbable tip 23 may be detached from the wire 27 and deposited in the puncture PP to assist with sealing the puncture PP.
- the bioabsorbable tip 23 can be made from a variety of materials including polyethylene glycol, polylactic acid, collagen, a bioadhesive glue, or a combination of these or other bioabsorbable materials. It is understood that tip 23 alternatively may be any biocompatible material that is not bioabsorbable, but instead suitable for implantation in the body. Such a tip may be either removed later or remain in the body.
- the tamponading member 21 may be mechanically, electrically, pneumatically or hydraulically expanded and collapsed without departing from the scope of the invention.
- the particular expanded exterior configuration of the tamponading member 21 can be selected depending on the particular circumstances of use.
- the criteria that is used to determine the particular size and configuration is the blood vessel condition at the puncture PP and the cross-sectional size and shape of the blood vessel lumen BVL in the vicinity of the puncture PP.
- the largest cross-sectional dimension of the expanded tamponading member 21 may be small enough for the member 21 to be pulled back against the interior end of the puncture PP without dragging or hanging up in the blood vessel lumen BVL. It has been found that an expanded dimension in one direction for the member 21 that is at least about 1.5 times larger than the puncture PP is satisfactory to prevent the tamponading member 21 from being pulled back through the puncture PP under typical conditions.
- One function of the tamponading member 21 is to seal the body cavity so that fluid does not leak from the cavity in the puncture PP.
- the portion of the tamponading member 21 near the puncture PP may be larger in cross-sectional area than the cross-sectional area of the puncture PP to insure sealing when the tamponading member 21 is pulled back up against the interior end of the puncture PP. While different expanded sizes may be used, dimensions on the order of 0.150-0.200 inch (3.8-5.1 mm) may be successful under typical conditions where the puncture PP is made with a 4 french needle.
- the particular temporary sealing component 11 illustrated may be a balloon catheter with the tamponading member 21 illustrated in Figure 2 as a small inflatable balloon which can be inflated.
- the tamponading member 21 has a puncture facing surface formed at the radius between the tamponading member 21 and control member 20 that serves to substantially center the control member 20 in the end of the puncture PP and maintain the end of the puncture PP closed. This is because the tamponading member 21 may shift in the end of the puncture PP until the force exerted on the tamponading member 21 by the blood vessel wall BVW and the body tissue BT is equally distributed around the control member 20.
- the tamponading member 21 is inflated and deflated through the control member 20 as will become more apparent.
- the inflatable tamponading member 21 may be made out of any suitable material such as latex. In alternate embodiments where the tamponading member 21 is mechanically expanded, it may be made of a metallic mesh which may or may not include a flexible covering.
- the control member 20 is a thin elongate flexible member considerably smaller than the puncture PP.
- the diameter of the control member 20 may be about 0.03 inch in procedures involving the femoral artery.
- the control member 20 is sufficiently long to extend from within the blood vessel lumen BVL out through the puncture PP exteriorly of the patient so that it can be manually manipulated.
- the control member 20 defines an inflation lumen 30 therethrough that extends from the valve 28, through second coupling 25, and to the interior of the tamponading member 21 along the length of the control member 20.
- the tamponading member 21 can be inflated and deflated through the lumen 30 from a position external of the patient.
- the tamponading member 21 can be expanded and contracted by any of a variety of mechanical, electromechanical, pneumatic, or hydraulic techniques. As illustrated in the exemplary embodiment shown in Figure 2, the tamponading member 21 is inflated by any convenient fluid inflation device such as syringe 26.
- the syringe 26 or other inflation device may be of the same type as that already used in balloon angioplasty and is connected to the exterior end of the control member 20 through valve 28 used to selectively seal the inflation lumen 30.
- the inflation fluid under pressure from the syringe 26 flows along the inflation lumen 30 in the control member 20 into the tamponading member 21 to selectively inflate same.
- the syringe 26 also is used to collapse the tamponading member 21 when it is to be withdrawn as described further below.
- an exemplary embodiment of the sealing system 10 is illustrated as inserted through a guide sheath GS.
- the guide sheath GS may be in place in puncture PP in connection with a surgical procedure. While the exemplary embodiment shown in Figure 3 involves inserting the sealing system 10 through a guide sheath GS, the guide sheath GS is not required for use with the sealing system 10.
- the sealing system 10 can be inserted through guide sheath GS until delivery tube 60, control member 20, tamponading member 21 , and bioabsorbable tip 23 are positioned within the blood vessel BV.
- the exemplary embodiment shown in Figure 3 illustrates the first coupling 63 up against the hub 70 of the guide sheath GS.
- the first coupling 63 of sealing system 10 may be attached to the hub 70 of guide sheath GS.
- Such an attaching feature can be useful for fixing the position of the sealing system 10 relative to the guide sheath GS.
- the first coupling 63 may be attached to the hub 70 of guide sheath GS through a variety of mechanisms including threads, clips, snaps, protrusions, or recesses.
- the tamponading member 21 is within the blood vessel BV 1 it can be inflated so that its cross-sectional area is larger than the cross-sectional area of the puncture PP. While not shown in Figure 3, the tamponading member 21 is inflated using an expanding mechanism such as syringe 26 shown in Figure 2. In this exemplary embodiment, the syringe 26 is coupled to valve 28 and a fluid or gas is pushed from the syringe 26, through the inflation lumen 30 in control member 20, and into the tamponading member 21.
- an expanding mechanism such as syringe 26 shown in Figure 2.
- the syringe 26 is coupled to valve 28 and a fluid or gas is pushed from the syringe 26, through the inflation lumen 30 in control member 20, and into the tamponading member 21.
- sealing system 10 an exemplary embodiment of sealing system 10 is illustrated with the sealing system 10 in a retracted position.
- both the sealing system 10 and the guide sheath GS have been retracted so that tamponading member 21 has been pulled up against the puncture PP in the blood vessel wall BVW.
- the tamponading member 21 has been inflated to a cross-sectional size greater that the cross- sectional size of the puncture PP, the tamponading member 21 remains up against the blood vessel wall BVW and may not pass into the puncture PP.
- the delivery tube 60 of the sealing material delivery component 12 has been retracted to a position where its distal end 64 is located within the puncture PP but proximate to the distal end of the puncture PP.
- the relative location of the distal end 64 of the delivery tube 60 with respect to the tamponading member 21 can be adjusted depending on the type of procedure and the patient.
- an exemplary embodiment of the sealing system 10 is illustrated performing the deposit of the first stage of sealing material 67 in the puncture PP.
- the first stage of sealing material 67 can be mixed outside of the sealing system 10, for example, in a double-barrel syringe (not shown).
- the mixed first stage of sealing material 67 is then injected into first sealing material port 65 and flows through cavity 31 in delivery tube 60.
- the first stage sealing material 67 can be mixed in cavity 31 as it flows along the inside of the delivery tube 60.
- the distal end 64 of delivery tube 60 has been positioned proximate to the blood vessel wall BVW.
- the first stage sealing material 67 exits the delivery tube 60 at the distal end 64 and is deposited in the region immediately proximate to the blood vessel wall BVW creating a seal where the puncture PP passed through the blood vessel wall BVW.
- the seal created with the first stage sealing material 67 may not be a complete seal because control member 20 still passes through the first stage sealing material 67 and into the blood vessel BV.
- the first stage sealing material 67 can be a solid material with a preformed hollow center through which the control member 20 passes.
- the solid material with the preformed hollow center can be pushed into the puncture PP or deposited in the puncture PP by a modified version of the sealing system 10 so that the solid material is positioned proximate to the blood vessel wall BVW.
- the exemplary sealing system 10 is illustrated with the step of removing the temporary sealing component 11.
- the tamponading member 21 is contracted by releasing the valve 28 so that the liquid or gas can pass out of the tamponading member 21 , back up the inflation lumen 30 and into the syringe 26 (not shown).
- the surgeon can rotate the second coupling 25 as shown in the exemplary embodiment in Figure 6. Rotating the second coupling 25 causes the temporary sealing component 11 to retract and separate from the sealing material delivery component 12.
- the second coupling 25 is attached to the first coupling 63 using threads.
- the threads allow the second coupling 25 and the temporary sealing component 11 to be gently separated from the sealing material delivery component 12.
- the second coupling 25 and the first coupling 63 can be connected and detached using alternate mechanisms such as clips, snaps, protrusions, or recesses.
- Certain embodiments of the sealing system 10 may employ an additional sheath (not shown) around the control member 20 where the additional sheath is made of a material that resists adhesion to the first stage sealing material 67 and facilitates retraction of the control member 20 from the first stage sealing material 67.
- the bioabsorbable tip 23 may pass into the tract in the first stage sealing material 67 and serve to fill the hollow space defined by the tract. In this way the bioabsorbable tip 23 provides an improved method for completely sealing the puncture PP.
- a variety of mechanisms may be employed to release the bioabsorbable tip 23 from the wire 27 so that it may be deposited in the tract in the first stage sealing material 67.
- the bioabsorbable tip 23 is larger in diameter than the distal end 64 of the delivery tube 60.
- the bioabsorbable tip 23 engages the distal end 64 of delivery tube 60 and with sufficient tension, the bioabsorbable tip 23 breaks off of the wire 27 and remains in the tract.
- the bioabsorbable tip 23 may be released from the temporary sealing component 1 1 using a mechanical or electro-mechanical release mechanism.
- the bioabsorbable tip 23 can be designed to fracture under a certain tension so that a portion of the bioabsorbable tip 23 breaks free of the wire 27 and is deposited in the tract.
- FIG 7 an exemplary embodiment of the sealing system 10 is illustrated with the temporary sealing component 11 having been removed as described in connection with Figure 6.
- Figure 7 illustrates the final step of the exemplary sealing process, namely, the depositing of the second stage sealing material 68 in the puncture PP.
- the bioabsorbable tip 23 remains within the tract in the first stage sealing material 67 proximal to the blood vessel wall BVW.
- the second stage sealing material 68 can be used to fill the remainder of the puncture PP as well as to seal off any remaining gaps in and around the tract and the first stage sealing material 67.
- the second stage sealing material 68 may either have the same or a different composition from the first stage sealing material 67.
- the second stage sealing material 68 is mixed outside the sealing system 10, for example, in a double-barrel syringe, and is injected into the first sealing material port 65.
- the second stage sealing material 68 flows through cavity 32 because cavity 31 may be impassable because it is filled with the first stage sealing material 67 which may have set.
- cavity 32 may have a one-way valve so that the second stage sealing material 68 passes down the cavity 32 toward the distal end 64 and not in the opposite direction and out the proximal end of first coupling 63.
- the second stage sealing material 68 is injected through a second sealing material port (not shown).
- the second stage sealing material 68 is not mixed until it passes along the cavity 32 within the delivery tube 60.
- the second stage sealing material 68 exits the distal end 64 of delivery tube 60 and fills the remainder of the puncture PP. As the second stage sealing material 68 is deposited, the surgeon can retract the sealing material delivery component 12. The second stage sealing material 68 can be used to completely fill and seal the puncture PP.
- Figure 8 shows an embodiment of a sealing system 112 including temporary sealing component 11.
- the guide sheath GS remains through the skin SK and body tissue BT during the closure of the percutaneous puncture PP.
- FIG. 8 illustrates a coupling 71 disposed up against hub 70 of the guide sheath GS.
- the coupling 71 of sealing system 112 may be attached to hub 70 of the guide sheath GS.
- Such an attaching feature can be useful for fixing the position of the sealing system 112 relative to the guide sheath GS.
- An additional benefit of having guide sheath GS remain through the skin SK and body tissue BT is that the guide sheath GS seals the tract and/or acts as a cork and provides a confined space that forces the sealing material to remain within the body tissue BT.
- Another benefit of having guide sheath GS remain through the skin SK and body tissue BT is the ability to aspirate any fluid that may be present within the body tissue BT tract.
- a syringe can be attached to luer fitting 76 to apply a vacuum and aspirate fluid from body tissue BT.
- a benefit of aspirating any fluid or blood from tract puncture PP is the ability to verify that the tamponading member 21 has been pulled up against blood vessel wall BVW and has sealed the puncture PP.
- Coupling 71 may be attached to hub 70 with a variety of means and at a variety of locations.
- coupling 71 may be attached to the outside or inside of hub 70, to proximal or distal ends of hub 70, or onto the shaft 74, 75 of guide sheath GS.
- the coupling 71 may be attached to the hub 70 of the guide sheath GS through a variety of mechanisms including threads, clips, snaps, protrusions or recesses.
- Figures 9 and 10 show an exemplary embodiment of the sealing system 112 inserted through guide sheath GS.
- the guide sheath GS remains in the tract and guide sheaths GS of different lengths may be accommodated.
- Guide sheath GS may be in place in puncture PP in connection with a surgical procedure.
- Guide sheath GS may be manufactured in a variety of different shapes and lengths and the following will illustrate how to accommodate for the variability of guide sheath lengths.
- sealing system 112 is inserted through the guide sheath GS until tamponading member 21 exits the distal end of guide sheath GS.
- the tamponading member 21 is activated to an expanded state and sealing system 112 is withdrawn until the distal end of guide sheath GS is in contact with tamponading member 21.
- Coupling 71 is advanced distally until coupling component 86 is in contact and secured to hub 70 of guide sheath GS.
- Coupling 71 allows sealing system 112 to be attached to hub 70, and the distal end of guide sheath GS to be within a known distance from tamponading member 21 , as will be described.
- Coupling component 84 is secured to delivery tube 60.
- Coupling component 84 can be attached to delivery tube 60 through a variety of mechanisms including threads, clips, snaps, protrusions or recesses.
- Coupling 71 may include coupling components 84, 85, 86, as shown in Figure 9. Coupling component 86 may be slidably received in coupling component 85, and coupling component 85 may be slidably received in coupling component 84 to allow for telescoping movement between coupling components 84, 85, 86.
- the telescoping movement allows the length of coupling 71 (i.e., the distance between the distal end of coupling component 86 or hub 70, and the proximal end of coupling component 84) to be adjustable between length X shown in Figure 9 to length Y shown in Figure 10. Accordingly, the length of coupling 71 is adjustable between length X when coupling 71 is in an extended configuration and length Y when coupling 71 is in a collapsed configuration.
- Attachment of coupling 71 to guide sheath GS provides a means of setting a defined distance between tamponading member 21 , distal end of guide sheath GS and distal end of delivery tube 60.
- a coupling release mechanism 87 is activated to allow components 85 and 86 to compress (or telescope) together into coupling component 84.
- Release mechanism 87 can be made by a variety of mechanisms including threads, clips, snaps, protrusions or recesses.
- release mechanism 87 may include a push button attached to a spring release that permits coupling components 84, 85, 86 to telescope into the collapsed configuration shown in Figure 10 after pressing the push button.
- coupling component 84 is secured to delivery tube 60 and coupling component 86 is secured to hub 70 of guide sheath GS, when coupling 71 is collapsed, delivery tube 60 and hub 70 of guide sheath GS are moved with respect to each other. Since tamponading member 21 is connected to delivery tube 60 via connector 14, guide sheath GS also moves with respect to tamponading member 21. The distance that the guide sheath GS moves with respect to tamponading member 21 may generally equal the distance that coupling 71 is shortened (length X - length Y).
- Shortening or collapsing coupling 71 retracts guide sheath GS from tamponading member 21 to a set distance (length X - length Y).
- the set distance between tamponading member 21 and the distal end of guide sheath GS may be 10mm (0.3937 inch).
- the set distance can range from 2mm- 20mm (0.079-0.79 inch).
- Physicians use a variety of different length guide sheath GS and the method described above provides a means of adjusting and/or consistently setting a distance between the distal end of the guide sheath GS and the tamponading member 21 independent of guide sheath GS length.
- coupling 71 allows the physician to move guide sheath GS with respect to tamponading member 21 without pulling guide sheath GS out of puncture PP. Shortening coupling 71 also creates sufficient space between the distal end of guide sheath GS and tamponading member 21 for injecting sealing material.
- FIG. 11 shows a further embodiment of the sealing system 112 including temporary sealing component 11.
- a known tension may be applied to the sealing system 112.
- the sealing system 112 has been retracted so that tamponading member 21 has been pulled up against the puncture PP in the blood vessel wall BVW.
- a hub 72 and compression spring 73 may be provided.
- Delivery tube 60 may be slidably received in hub 72, and hub 72 may be connected to a distal end of compression spring 73. A proximal end of compression spring 73 may be connected to a distal end of first coupling 63.
- the physician may hold on to and pull hub 72 in the proximal direction (as shown by the arrows in Figure 1 1 ), thereby compressing compression spring 73 and forcing sealing system 112 (e.g., first or second couplings 63, 25) in the proximal direction.
- sealing system 112 e.g., first or second couplings 63, 25
- tamponading member 21 which is attached to second coupling 25 by control member 20, is pulled upward against blood vessel wall BVW.
- the physician may pull hub 72 and sealing system 112 and compress compression spring 73 until a desired force is applied to blood vessel wall BVW.
- a scale 61 with numerical indices could be used to help guide the physician to apply a consistent amount of tension.
- the numerical indices may correspond to the amount of compression of compression spring 73 and may be provided, e.g., on an outer surface of delivery tube 60, as shown in Figure 1 1.
- Applying a known load to sealing system 112 may permit the positioning of tamponading member 21 at a set distance from puncture PP consistently during the delivery of first stage delivery material 67 and bioabsorbable tip 23.
- hub 72 may be attached to a variety of other mechanisms including a compression spring, an expansion spring, a polymer band, or other stretchable and/or biasing member.
- FIG 11 shows an embodiment of sealing system 112 in which a skin securement hub 77 may be attached to guide sheath GS.
- skin securement hub 77 may be attached to skin SK.
- Guide sheath GS may be inserted into and positioned within skin securement hub 77, as shown in Figure 1 1.
- Skin securement hub 77 includes a cover 78, which may be closed to secure skin securement hub 77 to guide sheath GS and to secure guide sheath GS and sealing system 112 in position. For example, closing cover 78 onto skin securement hub 77 may cause skin securement hub 77 to be squeezed, compressed, or locked onto guide sheath GS.
- Skin securement hub 77 can be secured to skin SK using adhesive tape or secured mechanically under skin SK.
- sealing system 112 maintains a consistent distance between delivery tube 60 and tamponading member 21 during delivery of the first stage sealing material 67.
- An additional benefit of securing sealing system 112 in position is that the delivery tube 60 position is maintained during the removal of tamponading member 21 and the separation of bioabsorbable tip 23. Securing sealing system 112 in place also maintains a consistent deployment location of the bioabsorbable tip 23. Also, maintaining position of sealing system 112 with skin securement hub 77 may maintain a consistent delivery location for delivering second stage sealing material 68. Securing sealing system 112 in place with skin securement hub 77 also allows the physician to free one or more hands, which would have been used to hold sealing system 112 in place.
- Figure 12 shows an additional embodiment of sealing system 112 secured to a skin securement hub 79 that is attached to delivery tube 60.
- Skin securement hub 79 may include a cover, e.g., cover 78, and may be secured to delivery tube 60 in a similar manner as described above for securing skin securement hub 77 to guide sheath GS.
- Skin securement tube 79 includes a tube 80 inserted through skin SK and body tissue BT. Instead of guide sheath GS, tube 80 may seal the tract, act as a cork, and provide a confined space that forces the first stage sealing material 67 to remain within body tissue BT.
- a syringe can be attached to luer fitting 81 to apply a vacuum and aspirate fluid from body tissue BT prior to delivery of first stage sealing material 67.
- Skin securement hub 79 can be secured to skin SK using frictional engage réelle or adhesive tape, or is secured mechanically under skin SK.
- Figure 13 shows an additional embodiment of sealing system 112 in which delivery tube 60 is retracted prior to delivery of second stage sealing material 68 by retracting coupling 71 from hub 70.
- a syringe may be attached to a luer fitting 82 in first coupling 63, and luer fitting 82 may be fluidly connected to cavity 31 ( Figure 1 ) in delivery tube 60 so that first stage sealing material 67 may be delivered from the syringe through cavity 31 in delivery tube 60. After passing through cavity 31 , first stage sealing material 67 may seal or block cavity 31.
- a luer fitting 83 may be provided in first coupling 63 and fluidly connected to cavity 32 ( Figure 1 ) in delivery tube 60.
- a syringe may be attached to luer fitting 83 to deliver second stage sealing material 68 through cavity 32 in delivery tube 60.
- coupling 71 Prior to delivery of second stage sealing material 68, coupling 71 may be separated from hub 70 to retract coupling 71 from hub 70. While different separation distances may be used, distances on the order of 1-10 mm (0.039-0.39 inch) may be desirable. Alternatively, the retraction of coupling 71 from hub 70 could take place without separating the two components. Coupling 71 and hub 70 could be connected by a hinge mechanism, slide or telescoping tubes (not shown) that allows the physician to retract coupling 71 from hub 70, and retract delivery tube 60 to a predetermined distance.
- Delivery tube 60 may be retracted so that the distal end of delivery tube 60 is approximately flush with the distal end of guide sheath GS, or so that the delivery tube 60 extends outward from or inward into the distal end of the guide sheath GS up to a distance, e.g., 5mm, which may be a predetermined distance.
- second stage sealing material 68 can be delivered through luer fitting 83. The delivery of second stage sealing material 68 seals the remaining channel.
- FIG. 14 shows an additional embodiment that allows the second stage sealing material 68 to be delivered through the guide sheath GS.
- the tamponading member 21 and sealing system 112 are removed from the guide sheath GS.
- Bioabsorbable tip 23 remains in the tract.
- the second stage sealing material 68 is supplied through luer 76 of the guide sheath GS.
- the second stage sealing material 68 is injected through the guide sheath GS and seals the remaining channel.
- Figure 15 shows an additional embodiment of sealing system 112 having an expandable member 88 fixedly attached to delivery tube 60 and expanded within body tissue BT.
- Sealing system 112 is inserted through guide sheath GS. Tamponading member 21 is expanded and sealing system 1 12 is retracted so that tamponading member 21 is pulled up against the puncture PP in the blood vessel wall BVW.
- Guide sheath GS is retracted from body tissue BT.
- Delivery tube 60 may include an additional channel (not shown) fluidly connecting expandable member 88 to a luer 89 in first coupling 63.
- a syringe may be attached to luer 89 to deliver gas or liquid through the channel in delivery tube 60 to expand or contract the expandable member 88.
- Expandable member 88 provides numerous benefits.
- the position of sealing system 1 12 may be secured to maintain a consistent distance between delivery tube 60 and tamponading member 21 during delivery of the first stage sealing material 67.
- An additional benefit of securing sealing system 112 in position is that the delivery tube 60 position is maintained during the removal of tamponading member 21 and the separation of bioabsorbable tip 23. Securing sealing system 112 in place maintains a consistent deployment location of the bioabsorbable tip 23.
- maintaining position of sealing system 112 may maintain a consistent delivery location for delivering second stage sealing material 68.
- expandable member 88 seals the tract and/or acts as a cork and provides a confined space that forces the sealing material to remain within the body tissue BT.
- the expandable member 88 can be created by many means, such as, expandable balloon, expandable disc, telescoping tubes, etc.
- Figure 16 shows an additional embodiment of sealing system 112 with expandable member 88 fixedly attached to delivery tube 60 and expanded within guide sheath GS.
- Sealing system 112 is inserted through guide sheath GS. Tamponading member 21 is expanded and sealing system 112 is retracted so that tamponading member 21 is pulled up against the puncture PP in the blood vessel wall BVW.
- Guide sheath GS is retracted and secured onto coupling 71.
- a syringe may be attached to luer 89 as described above to deliver gas or liquid through the channel in delivery tube 60 to expand or contract the expandable member 88.
- Expandable member 88 provides numerous benefits.
- the expandable member 88 seals the guide sheath GS and/or acts as a cork and prevents the first stage delivery material 67 from entering the guide sheath GS.
- An additional benefit is the ability to center the sealing system 112 and control member 20 within the percutaneous puncture PP.
- Centering control member 20 may help facilitate centering the hollow space or tract within first stage sealing material 67 and positioning bioabsorbable tip 23 within the center of the percutaneous puncture PP. This is beneficial when closing larger bore percutaneous punctures PP, such as punctures PP produced by a 12-24 french guide sheath.
- the position of the expandable member could be completely within the guide sheath GS or partially exiting the distal end of guide sheath GS.
- the tamponading member 21 may serve as a bioabsorbable tip, and a separate bioabsorbable tip (e.g., bioabsorbable tip 23) may be omitted.
- a separate bioabsorbable tip e.g., bioabsorbable tip 23
- the tamponading member 21 may become the bioabsorbable tip 23 and may provide an improved method for completely sealing the puncture PP.
- Tamponading member 21 and/or bioabsorbable tip 23 can be made from a variety of materials including polyethylene glycol, polylactic acid, polyglycolic acid, collagen, poly-ether-ester or a combination of these or other bioabsorbable materials. Alternatively, tamponading member 21 and/or tip 23 may be nonbioabsorbable. Other materials for forming tamponading member 21 and/or tip 23 may include stainless steel, titanium, nitinol, P.E.E.K., P.E.T., silk, hydrogel, a two-part liquid compound, etc.
- tamponading member 21 may be released using a mechanical or electro-mechanical release mechanism, including any of the mechanisms described in this disclosure, or by fracturing or breaking off a portion of tamponading member 21.
- FIGS 17-19 show an exemplary embodiment of sealing system 112 with an insert member 92 attached to control member 20.
- Insert member 92 creates a hollow cavity 90, which may be a hollow geometry pocket with a defined shape within first stage sealing material 67.
- the size and/or shape of hollow cavity 90 may be similar to the size and/or shape of bioabsorbable tip 23.
- bioabsorbable tip 23 may be disconnected from temporary sealing component 1 1 and positioned within hollow cavity 90.
- insert member 92 on control member 20 may be positioned in percutaneous puncture PP during the delivery of first stage sealing material 67.
- hollow cavities 90, 91 may be formed in first stage sealing material 67.
- hollow cavity 90 may be created by removing insert member 92 from first stage sealing material 67 after first stage sealing material 67 has set, and/or hollow cavity 91 may be created by removing delivery tube 60 from first stage sealing material 67 after first stage sealing material 67 has set.
- bioabsorbable tip 23 may be positioned within hollow cavity 90 and released as described above in connection with Figures 6 and 7, or in any other suitable fashion.
- Second stage sealing material 68 may be delivered within hollow cavity 91.
- Hollow cavity 90 may have one of many different shapes depending on the geometry of insert member 92. Insert member 92 may be smaller or approximately the same size as bioabsorbable tip 23. Hollow cavity 90 may be smaller than bioabsorbable tip 23 to help secure bioabsorbable tip 23 and prevent second stage sealing material 68 from traveling distally during injection of second stage sealing material 68. [0113] Insert member 92 may have a fixed shape or may be expandable to create a larger shape prior to the delivery of first stage delivery material 67. For example, expandable insert member 92 may be a balloon.
- Expandable insert member 92 may be positioned in percutaneous puncture PP in a nonexpanded condition and expanded prior to delivering first stage sealing material 67 to the percutaneous puncture PP ( Figure 17). After delivering first stage sealing material 67, the expanded insert member 92 may be changed to its nonexpanded shape and removed from hollow cavity 90 ( Figure 18). Then, bioabsorbable tip 23 may be positioned within hollow cavity 90 ( Figure 19).
- insert member 92 may be formed from a flexible (e.g., a gummy, elastic, etc.) material that allows insert member 92 to change shape and/or be squeezed to allow insert member 92 to be inserted into and removed from hollow cavity 90.
- the expandable insert member 92 may be positioned in percutaneous puncture PP in an unstressed (or normal) shape and/or condition prior to delivering first stage sealing material 67 to the percutaneous puncture PP ( Figure 17). After delivering first stage sealing material 67, control member 20 may be pulled proximally with respect to the puncture so that insert member 92 is pulled out of hollow cavity 90 ( Figure 18).
- insert member 92 may change shape and/or be squeezed through a narrower cavity formed by control member 20 in first stage sealing material 67 proximal to hollow cavity 90 (e.g., a narrow cavity formed between hollow cavity 90 and hollow cavity 91 ). Then, bioabsorbable tip 23 may be positioned within hollow cavity 90 ( Figure 19).
- insert member 92 may be one of the various shapes described in this disclosure for bioabsorbable tip 23.
- Insert member 92 may be formed of one or more of the materials described above for forming bioabsorbable tip 23.
- Insert member 92 may be formed integrally with control member 20, or may be formed separate from control member 20 and attached to control member 20.
- a variety of methods may be used to determine and monitor the location of bioabsorbable tip 23 prior to its separation from temporary sealing component 11. As described above, pulling tamponading member 21 against the interior of blood vessel wall BVW allows the surgeon to confirm the location of sealing system 10, 112 and delivery tube 60. Also, a clip may be installed on delivery tube 60 to indicate where delivery tube 60 exits skin SK and to assist in determining the distance between distal end 64 of delivery tube 60 and blood vessel wall BVW. Then, the location of bioabsorbable tip 23 may be determined based on the location of distal end 64 of delivery tube 60 since the distance between temporary sealing component 11 and sealing material delivery component 12 (e.g., adjusted using connector 14) is known.
- Blood pressure may also be used to assist the user to identify the position of bioabsorbable tip 23 prior to its detachment from temporary sealing component 11.
- a pressure transducer (not shown) may be attached to temporary sealing component 11 and may provide an arterial pressure reading that may be recorded while temporary sealing component 11 is within blood vessel lumen BVL. While temporary sealing component 11 is withdrawn from blood vessel lumen BVL, the arterial pressure may be monitored until a pressure drop occurs (e.g., when pressure drops a predetermined amount), which may indicate that bioabsorbable tip 23 is positioned within first stage sealing material 67.
- Temporary sealing component 11 may include a lumen (not shown), e.g., located in wire 27 with a distal opening that is distal or proximal to bioabsorbable tip 23. The user may allow a small amount of blood to flow through the lumen while bioabsorbable tip 23 is within blood vessel lumen BVL. Stoppage of the blood flow in the lumen may indicate that bioabsorbable tip 23 is withdrawn and positioned within first stage sealing material 67.
- Another method of identifying the location of bioabsorbable tip 23 is with the use of fluoroscopy or other imaging techniques used to view internal structures of a patient.
- a radiopaque filler or marker or other type of identifiable material may be placed within bioabsorbable tip 23.
- the user may watch, e.g., on a fluoroscope, the movement of the radiopaque marker to identify when bioabsorbable tip 23 is positioned within first stage sealing material 67.
- Radiopaque fillers or markers may also be added to first stage sealing material 67 to help visualize first stage sealing material 67 during delivery.
- Bioabsorbable tip 23 may be formed in one of a variety of shapes. For example, as shown in Figures 2-17, bioabsorbable tip 23 may be elongate with a cylindrical, rectangular, or other type of cross section. Figures 20-27 show exemplary embodiments of the various shapes that bioabsorbable tip 23 may have. [0121] Figure 20 shows an embodiment of bioabsorbable tip 23 with a body 94, and one or more barbs 93 secured to the sides of body 94. Barbs 93 may be flexible and may allow bioabsorbable tip 23 to pass through first stage sealing material 67 in one direction, e.g., proximally, with a small amount of resistance.
- Barbs 93 may open or catch, and become engaged or lock on to first stage sealing material 67 to prevent bioabsorbable tip 23 from moving distally.
- Barbs 93 may be made of rigid, semi-rigid, or soft materials. As shown in Figure 20, barbs 93 may be pointed or tapered, and may extend from body 94 at an angle relative to a longitudinal axis of body 94. Barbs 93 may be angled towards a distal end of body 94. Barbs 93 may provide a liquid seal between bioabsorbable tip 23 and first stage sealing material 67. As a result, when delivering second stage sealing material 68, barbs 93 may prevent second stage sealing material 68 from entering blood vessel lumen BVL. Barbs 93 may also prevent blood from flowing proximally past bioabsorbable tip 23.
- FIG. 21 shows an embodiment of bioabsorbable tip 23 with a body 96, and one or more rings 95 around body 96.
- Rings 95 may be constructed of the same material as body 96 and may be formed integral with body 96. Rings 95 may be flexible or rigid. Rings 95 may provide stability to bioabsorbable tip 23 within first stage sealing material 67. Rings 95 may also provide a liquid seal between bioabsorbable tip 23 and first stage sealing material 67. As a result, when delivering second stage sealing material 68, rings 95 may prevent second stage sealing material 68 from entering blood vessel lumen BVL. Rings 95 may also prevent blood from flowing proximally past bioabsorbable tip 23.
- FIG. 22 shows an embodiment of bioabsorbable tip 23 with a body 98, and one or more rings 97 around body 98.
- Rings 97 may be made of a different material than body 98. Rings 97 may be flexible or rigid. Rings 97 may provide stability to bioabsorbable tip 23 within first stage sealing material 67. Rings 97 may also provide a liquid seal between bioabsorbable tip 23 and first stage sealing material 67. As a result, when delivering second stage sealing material 68, rings 97 may prevent second stage sealing material 68 from entering blood vessel lumen BVL. Rings 97 may also prevent blood from flowing proximally past bioabsorbable tip 23.
- FIG. 23 shows an embodiment of bioabsorbable tip 23 that is expandable.
- bioabsorbable tip 23 may be formed from expandable materials, such as materials that expand when in contact with a liquid, e.g., blood.
- bioabsorbable tip 23 may include an expandable structure, e.g., an expandable balloon, and the size of the expandable structure may be controlled by the user.
- Bioabsorbable tip 23 may enter blood vessel lumen BVL in the smaller, unexpanded configuration 99, and may be opened or expanded to the larger, expanded configuration 100 when in contact with blood or otherwise activated.
- the expanded configuration 100 may provide stability to bioabsorbable tip 23 within first stage sealing material 67.
- a liquid seal may form between bioabsorbable tip 23 and first stage sealing material 67.
- expanded configuration 100 of bioabsorbable tip 23 may prevent second stage sealing material 68 from entering blood vessel lumen BVL. Expanded configuration 100 of bioabsorbable tip 23 may also prevent blood from flowing proximally past bioabsorbable tip 23.
- FIG. 24 shows an embodiment of bioabsorbable tip 23 including a suture 120.
- Suture 120 may include a main body 121 with a knot 122 tied within main body 122 of suture 120.
- FIG. 25 shows an embodiment of bioabsorbable tip 23 including a suture 130.
- Suture 130 may include a main body 131 with a knot 132 tied within main body 131 of suture 130.
- a flexible or rigid disc 133 may be located on suture 130 proximal to the knot 132.
- Each suture 120, 130 shown in Figures 24 and 25 may provide stability to bioabsorbable tip 23 within first stage sealing material 67.
- Each suture 120, 130 may also provide a liquid seal between bioabsorbable tip 23 and first stage sealing material 67.
- each suture 120, 130 may prevent second stage sealing material 68 from entering blood vessel lumen BVL.
- Each suture 120, 130 may also prevent blood from flowing proximally past bioabsorbable tip 23.
- Figure 26 shows an embodiment of bioabsorbable tip 23 including a braid configuration.
- the braid may be stretched to a lower picks per inch configuration 101 and compressed to a higher picks per inch 102 configuration.
- the higher picks per inch configuration 102 increases an outer dimension of the braid (e.g., the thickness, width, diameter, etc., of the braid) to assist in securing bioabsorbable tip 23 within first stage sealing material 67.
- the lower picks per inch configuration 101 provides a smaller outer dimension that may facilitate delivery of bioabsorbable tip 23 within first stage sealing material 67.
- the braid may include a plurality of strands that are braided together so that, when second stage delivery material 68 is delivered, second stage sealing material 68 may mold around the individual strands of the braid to help secure bioabsorbable tip 23 in place.
- the braid may provide stability to bioabsorbable tip 23 within first stage sealing material 67, and a liquid seal may form between bioabsorbable tip 23 and first stage sealing material 67.
- higher picks per inch configuration 102 of bioabsorbable tip 23 may prevent second stage sealing material 68 from entering blood vessel lumen BVL.
- bioabsorbable tip 23 may also prevent blood from flowing proximally past bioabsorbable tip 23.
- bioabsorbable tip 23 may include other configurations that are capable of stretching to decrease an outer dimension of bioabsorbable tip 23 and compressing to increase an outer dimension of bioabsorbable tip 23, such as a bellows-like configuration.
- FIG. 27 shows an embodiment of bioabsorbable tip 23 constructed of a body 103 with a soft pliable end 104.
- Body 103 may be semi-rigid so that bioabsorbable tip 23 is similar to a cotton swab.
- Pliable end 104 may be formed of a material that is fibrous, porous, spongy, etc. Pliable end 104 may provide stability to bioabsorbable tip 23 within first stage sealing material 67 and may also provide a liquid seal between bioabsorbable tip 23 and first stage sealing material 67. As a result, when delivering second stage sealing material 68, pliable end 104 may prevent second stage sealing material 68 from entering blood vessel lumen BVL. Pliable end 104 may also prevent blood from flowing proximally past bioabsorbable tip 23.
- bioabsorbable tip 23 may be smaller, larger, or generally the same size as the hollow cavity 90 or other tract formed within first stage sealing material 67.
- Bioabsorbable tip 23 may be positioned in one of a variety of locations with respect to first and second stage sealing materials 67, 68.
- Figures 28-31 show exemplary embodiments of locations of bioabsorbable tip 23 with respect to first and second stage sealing materials 67, 68.
- FIG 28 shows an embodiment of bioabsorbable tip 23 positioned within both first stage sealing material 67 and second stage sealing material 68.
- Bioabsorbable tip 23 may include a distal flange 105 and a proximal flange 106.
- Distal flange 105 may extend through blood vessel wall BVW and may prevent bioabsorbable tip 23 from moving proximally.
- Proximal flange 106 may rest within first stage sealing material 67, within second stage sealing material 68, or within both first and second stage sealing materials 67, 68.
- Proximal flange 106 may prevent bioabsorbable tip 23 from moving distally or proximally.
- Both distal and proximal flanges 105, 106 may also provide a seal between bioabsorbable tip 23 and first and second stage sealing materials 67, 68, e.g., to prevent second stage sealing material 68 from entering blood vessel lumen BVL.
- FIG 29 shows an embodiment of bioabsorbable tip 23 positioned within first stage sealing material 67.
- bioabsorbable tip 23 may include distal flange 105, which may extend through blood vessel wall BVW and may prevent bioabsorbable tip 23 from moving proximally.
- FIG 30 shows an embodiment of bioabsorbable tip 23 positioned within first stage sealing material 67 in close proximity to blood vessel wall BVW.
- bioabsorbable tip 23 may or may not extend through blood vessel wall BVW.
- Bioabsorbable tip 23 may extend at least partially through a hollow tract formed in first stage sealing material 67.
- bioabsorbable tip 23 may extend along a distal portion of the hollow tract in first stage sealing material 67 and second stage sealing material 68 may be delivered to a proximal portion of the hollow tract in first stage sealing material 67 so that a proximal end of bioabsorbable tip 23 may contact second stage sealing material 68.
- FIG 31 shows an embodiment of bioabsorbable tip 23 in contact with first stage sealing material 67 and second stage sealing material 68.
- Bioabsorbable tip 23 may extend at least partially through a hollow tract formed in first stage sealing material 67.
- Bioabsorbable tip 23 may extend along a proximal portion of the hollow tract in first stage sealing material 67 and a proximal end of bioabsorbable tip 23 may contact second stage sealing material 68.
- Bioabsorbable tip 23 may connect to temporary sealing component 11 using one of a variety of attachment and/or release mechanisms.
- Figures 32-34 show exemplary embodiments of mechanisms provided to releasably attach bioabsorbable tip 23 to temporary sealing component 11.
- FIG 32 shows an embodiment of a mechanism for releasably attaching bioabsorbable tip 23 to temporary sealing component 11.
- Temporary sealing component 11 may include or may be attached to a structure 107.
- structure 107 may be a distal end of wire 27 ( Figure 2) or may be attached to the distal end of wire 27.
- a distal end of structure 107 may include an end member 108 having an outer dimension (e.g., width, thickness, diameter, etc.) that is larger than the corresponding dimension of structure 107.
- Bioabsorbable tip 23 may be molded around end member 108 so that bioabsorbable tip 23 includes an inner structure configured to receive end member 108 when bioabsorbable tip 23 is attached to structure 107.
- end member 108 and/or the geometry of the molded inner structure of bioabsorbable tip 23 for receiving end member 108 may be modified to allow bioabsorbable tip 23 to detach from structure 107 with a desired release force, e.g., tensile force.
- FIG 33 shows another embodiment of a mechanism for releasably attaching bioabsorbable tip 23 to temporary sealing component 11.
- Temporary sealing component 11 may include or may be attached to a structure 109.
- structure 109 may be a distal end of wire 27 ( Figure 2) or attached to the distal end of wire 27.
- a distal end of structure 109 may include an end member 110 having an outer dimension (e.g., width, thickness, diameter, etc.) that is larger than the corresponding dimension of structure 109.
- Bioabsorbable tip 23 may be molded around end member 110 so that bioabsorbable tip 23 includes an inner structure configured to receive end member 1 10 when bioabsorbable tip 23 is attached to structure 109.
- end member 110 and/or the geometry of the molded inner structure of bioabsorbable tip 23 for receiving end member 110 may be modified to allow bioabsorbable tip 23 to detach from structure 109 with a desired release force, e.g., tensile force.
- FIGS 34 and 35 show a further embodiment of a mechanism for releasably attaching bioabsorbable tip 23 to temporary sealing component 11.
- Temporary sealing component 11 may include or may be attached to a structure 111.
- structure 111 may be a distal end of wire 27 ( Figure 2) or attached to the distal end of wire 27.
- structure 111 may include a surface that is configured to mate or engage with a corresponding surface on an end member 113 of bioabsorbable tip 23.
- Figure 34 shows the corresponding surfaces of structure 11 1 and end member 113 engaged so that bioabsorbable tip 23 is attached to temporary sealing component 11.
- a tube 114 disposed around wire 27 may slide distally over the engaged surfaces of structure 11 1 and end member 113.
- tube 114 may cover and therefore lock the engaged surfaces of structure 111 and end member 113 together.
- FIG 35 shows bioabsorbable tip 23 detached from temporary sealing component 11.
- tube 114 is pulled back (in the proximal direction) away from the engaged surfaces of structure 111 and end member 113. Uncovered, the engaged surfaces of structure 111 and end member 113 may be separated (e.g., by pulling temporary sealing component 11 in the proximal direction or otherwise applying a tensile force), thereby releasing bioabsorbable tip 23 from temporary sealing component 11.
- Another mechanism for releasably attaching bioabsorbable tip 23 to temporary sealing component 11 may include a member (not shown) formed of a material capable of breaking when sufficient tensile force is applied.
- a member made of a polymer may attach bioabsorbable tip 23 to temporary sealing component 11 , and the polymer may stretch when tensile force is applied. Necking may occur in the polymer when tensile force reaches a limit, which creates a break in the stretched polymer, thereby detaching bioabsorbable tip 23 from temporary sealing component 11.
- Tensile force may be applied when temporary sealing component 11 is pulled in the proximal direction and bioabsorbable tip 23 is held in place in first stage sealing material 67 and/or second stage sealing material 68.
- Other mechanisms for releasably attaching bioabsorbable tip 23 to temporary sealing component 11 may include a cutting mechanism to cut off bioabsorbable tip 23, a pinching mechanism to release bioabsorbable tip 23, a pull wire to release bioabsorbable tip 23, a threaded member to release bioabsorbable tip 23, a mechanism that applies heat to cause separation of bioabsorbable tip 23 from temporary sealing component 11 , etc. These mechanisms may be controlled to be able to cut or otherwise detach bioabsorbable tip 23 from temporary sealing component 1 1.
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11192667.1A EP2430982B1 (en) | 2008-08-26 | 2009-08-20 | System for sealing percutaneous punctures |
JP2011525104A JP5616891B2 (en) | 2008-08-26 | 2009-08-20 | Method and system for sealing a percutaneous puncture |
CA2734269A CA2734269A1 (en) | 2008-08-26 | 2009-08-20 | Method and system for sealing percutaneous punctures |
EP09791741.3A EP2330981B1 (en) | 2008-08-26 | 2009-08-20 | System for sealing percutaneous punctures |
AU2009288440A AU2009288440B2 (en) | 2008-08-26 | 2009-08-20 | Device and sealing component for sealing punctures |
US12/461,775 US8506592B2 (en) | 2008-08-26 | 2009-08-24 | Method and system for sealing percutaneous punctures |
US13/964,989 US8845683B2 (en) | 2008-08-26 | 2013-08-12 | Method and system for sealing percutaneous punctures |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19008508P | 2008-08-26 | 2008-08-26 | |
US61/190,085 | 2008-08-26 | ||
US21340709P | 2009-06-04 | 2009-06-04 | |
US61/213,407 | 2009-06-04 |
Publications (4)
Publication Number | Publication Date |
---|---|
WO2010027693A2 true WO2010027693A2 (en) | 2010-03-11 |
WO2010027693A3 WO2010027693A3 (en) | 2010-06-03 |
WO2010027693A8 WO2010027693A8 (en) | 2010-07-01 |
WO2010027693A4 WO2010027693A4 (en) | 2010-08-19 |
Family
ID=41137879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/054492 WO2010027693A2 (en) | 2008-08-26 | 2009-08-20 | Method and system for sealing percutaneous punctures |
Country Status (7)
Country | Link |
---|---|
US (2) | US8506592B2 (en) |
EP (2) | EP2430982B1 (en) |
JP (1) | JP5616891B2 (en) |
AU (1) | AU2009288440B2 (en) |
CA (1) | CA2734269A1 (en) |
CR (1) | CR20110105A (en) |
WO (1) | WO2010027693A2 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012148745A1 (en) * | 2011-04-25 | 2012-11-01 | St. Jude Medical Puerto Rico Llc | Distal balloon bond for temporary sealing location device and methods |
WO2013128292A3 (en) * | 2012-02-29 | 2014-03-06 | Vivasure Medical Limited | Percutaneous perforation closure systems, devices, and methods |
WO2014107393A1 (en) | 2013-01-03 | 2014-07-10 | Just Right Surgical, Llc | Medical device and method of use |
WO2014130107A1 (en) * | 2013-02-21 | 2014-08-28 | St. Jude Medical Puerto Rico Llc | Bioadhesive delivery system and methods for vascular closure |
WO2014130106A1 (en) * | 2013-02-21 | 2014-08-28 | St. Jude Medical Puerto Rico Llc | Detachable sealing plug with safety release mechanism and methods |
US9060751B2 (en) | 2010-12-30 | 2015-06-23 | Vivasure Medical Limited | Surgical closure systems and methods |
US9610070B2 (en) | 2007-06-15 | 2017-04-04 | Vivasure Medical Limited | Closure device |
US9750497B2 (en) | 2013-01-03 | 2017-09-05 | Just Right Surgical, Llc | Device for use in laparoscopic surgery and method of use |
US9850013B2 (en) | 2013-03-15 | 2017-12-26 | Vivasure Medical Limited | Loading devices and methods for percutaneous perforation closure systems |
US10206668B2 (en) | 2014-12-15 | 2019-02-19 | Vivasure Medical Limited | Implantable sealable member with mesh layer |
US10433826B2 (en) | 2014-12-15 | 2019-10-08 | Vivasure Medical Limited | Closure apparatus with flexible sealable member and flexible support member |
US11311280B2 (en) | 2015-12-15 | 2022-04-26 | Vivasure Medical Limited | Arteriotomy closure apparatus with slotted shoe for advantageous pressure distribution |
US11357486B2 (en) | 2009-12-30 | 2022-06-14 | Vivasure Medical Limited | Closure system and uses thereof |
US11653921B2 (en) | 2020-05-04 | 2023-05-23 | Bolder Surgical, Llc | Anti-buckling actuation members for a surgical instrument |
US11957328B2 (en) | 2021-02-26 | 2024-04-16 | Vivasure Medical Limited | Implants and methods for percutaneous perforation closure |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7790192B2 (en) | 1998-08-14 | 2010-09-07 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
GB0302409D0 (en) * | 2003-02-03 | 2003-03-05 | Depuy Int Ltd | A cup component of an orthopaedics joint prosthesis |
DE602006020488D1 (en) * | 2005-10-05 | 2011-04-14 | Univ Loma Linda Med | Vascular wound closure device |
US8617204B2 (en) | 2006-09-13 | 2013-12-31 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
US8333787B2 (en) | 2007-12-31 | 2012-12-18 | St. Jude Medical Puerto Rico Llc | Vascular closure device having a flowable sealing material |
US9364206B2 (en) | 2008-04-04 | 2016-06-14 | Access Closure, Inc. | Apparatus and methods for sealing a vascular puncture |
US8029533B2 (en) | 2008-04-04 | 2011-10-04 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
CA2962054C (en) | 2008-11-12 | 2019-08-06 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
EP2521493B1 (en) | 2010-01-06 | 2016-12-14 | St. Jude Medical, Inc. | System for sealing percutaneous punctures |
WO2011142821A1 (en) | 2010-05-12 | 2011-11-17 | St. Jude Medical, Inc. | Bioadhesive applicator and methods of sealing tissue punctures using same |
US9386968B2 (en) | 2011-05-11 | 2016-07-12 | Access Closure, Inc. | Apparatus and methods for sealing a vascular puncture |
US20120330352A1 (en) * | 2011-06-24 | 2012-12-27 | Accessclosure, Inc. | Transapical closure devices and methods for use |
US9492156B2 (en) | 2011-11-28 | 2016-11-15 | St. Jude Medical Puerto Rico Llc | Large bore anchor device |
EP2811913B1 (en) * | 2012-01-24 | 2017-11-01 | St. Jude Medical Puerto Rico LLC | Bioresorbable tip with low force release |
US9370345B2 (en) | 2012-01-24 | 2016-06-21 | St. Jude Medical Puerto Rico Llc | Bioadhesive delivery catheter manifold with mixing fixture and methods |
US9999410B2 (en) | 2012-03-20 | 2018-06-19 | St. Jude Medical Puerto Rico Llc | Systems and methods for sequential mixing of activator in bioadhesive delivery device |
US9757105B2 (en) | 2012-03-23 | 2017-09-12 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
US8721680B2 (en) | 2012-03-23 | 2014-05-13 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
US10010311B2 (en) | 2012-04-11 | 2018-07-03 | St. Jude Medical Puerto Rico Llc | Sealant mixing containers for extra vascular bioadhesive delivery systems and methods |
US9192386B2 (en) | 2012-08-24 | 2015-11-24 | St. Jude Medical Puerto Rico Llc | Bioadhesive mixing and delivery device and methods |
US10016200B2 (en) * | 2012-08-24 | 2018-07-10 | St. Jude Medical Puerto Rico Llc | Balloon bailout and bioadhesive delivery device for suture based closure and methods |
US9398913B2 (en) | 2012-08-24 | 2016-07-26 | St. Jude Medical Puerto Rico Llc | Sealant storage, preparation, and delivery systems and related methods |
US20140135830A1 (en) * | 2012-11-14 | 2014-05-15 | St. Jude Medical Puerto Rico Llc | Dual delivery systems, devices, and related methods for bioadhesives |
US9655604B2 (en) * | 2012-11-14 | 2017-05-23 | St. Jude Medical Puerto Rico Llc | Blocking sleeve for bioadhesive delivery device and methods |
WO2014077878A1 (en) | 2012-11-14 | 2014-05-22 | St. Jude Medical Puerto Rico Llc | Delivery tip for extravascular bioadhesive catheter and methods |
US9717487B2 (en) | 2012-11-14 | 2017-08-01 | St. Jude Medical Puerto Rico Llc | Bioadhesive mixing and preparation systems and methods using two syringes |
US9801631B2 (en) * | 2012-11-14 | 2017-10-31 | St. Jude Medical Puerto Rico Llc | Sheath and balloon tensioner and locator systems and methods |
US9655603B2 (en) | 2012-11-14 | 2017-05-23 | St. Jude Medical Puerto Rico Llc | Automatic sealant delivery catheter retraction for vascular closure device and methods |
US9955958B2 (en) * | 2013-02-06 | 2018-05-01 | St. Jude Medical Puerto Rico Llc | Extra-vascular closure device with releasable sealing plug |
US9668719B2 (en) * | 2013-02-19 | 2017-06-06 | St. Jude Medical Puerto Rico Llc | Vascular closure devices comprising force management features and related methods |
US9226739B2 (en) * | 2013-02-20 | 2016-01-05 | St. Jude Medical Puerto Rico Llc | Bioresorbable detachable tip design for adhesive-based extravascular closure device |
US9107646B2 (en) * | 2013-03-11 | 2015-08-18 | St. Jude Medical Puerto Rico Llc | Active securement detachable sealing tip for extra-vascular closure device and methods |
US9055933B2 (en) | 2013-03-12 | 2015-06-16 | St. Jude Medical Puerto Rico Llc | Large bore closure secondary hemostasis bioadhesive delivery systems and methods |
US10154835B2 (en) | 2013-05-09 | 2018-12-18 | Essential Medical, Inc. | Vascular closure device with conforming plug member |
US10085730B2 (en) | 2013-07-12 | 2018-10-02 | Phillips Medical, LLC | Hemostatic device and its methods of use |
US9839416B2 (en) | 2013-07-12 | 2017-12-12 | Phillips Medical, LLC | Hemostatic device and its methods of use |
US10028731B2 (en) | 2013-11-12 | 2018-07-24 | Genzyme Corporation | Barrier application device |
US9636505B2 (en) | 2014-11-24 | 2017-05-02 | AtaCor Medical, Inc. | Cardiac pacing sensing and control |
US10328268B2 (en) | 2014-09-04 | 2019-06-25 | AtaCor Medical, Inc. | Cardiac pacing |
US10743960B2 (en) | 2014-09-04 | 2020-08-18 | AtaCor Medical, Inc. | Cardiac arrhythmia treatment devices and delivery |
CA2959183C (en) | 2014-09-04 | 2023-10-10 | AtaCor Medical, Inc. | Receptacle for pacemaker lead |
MA40946A (en) | 2014-11-14 | 2017-09-19 | Access Closure Inc | APPARATUS AND METHODS FOR MAKING A VASCULAR PUNCTURE WATERTIGHT |
US11097109B2 (en) | 2014-11-24 | 2021-08-24 | AtaCor Medical, Inc. | Cardiac pacing sensing and control |
USD865166S1 (en) | 2015-11-13 | 2019-10-29 | Access Closure, Inc. | Sheath adapter |
USD847988S1 (en) | 2015-11-13 | 2019-05-07 | Access Closure, Inc. | Handle grip |
USD843573S1 (en) | 2015-11-13 | 2019-03-19 | Access Closure, Inc. | Vascular closure apparatus |
AU2017299466B2 (en) | 2016-07-18 | 2022-07-14 | Merit Medical Systems, Inc. | Inflatable radial artery compression device |
ES2686840A1 (en) * | 2017-04-19 | 2018-10-22 | Fundación Para El Fomento De La Investigación Sanitaria Y Biomédica De La Comunitat Valenciana | DURAL SEALING SYSTEM (Machine-translation by Google Translate, not legally binding) |
WO2018200701A1 (en) * | 2017-04-25 | 2018-11-01 | Emory University | Bone filling systems, devices, and methods of use |
US11284905B2 (en) | 2017-11-03 | 2022-03-29 | Merit Medical Systems, Inc. | Hemostasis devices and methods of use |
US11350945B2 (en) | 2017-11-13 | 2022-06-07 | Merit Medical Systems, Inc. | Staged deflation syringe systems and associated methods |
JPWO2019189759A1 (en) * | 2018-03-30 | 2021-04-08 | 日本ゼオン株式会社 | Hemostasis device and hemostatic kit |
WO2019199969A1 (en) | 2018-04-11 | 2019-10-17 | Merit Medical Systems, Inc. | Inflatable compression device |
WO2020243534A1 (en) | 2019-05-29 | 2020-12-03 | AtaCor Medical, Inc. | Implantable electrical leads and associated delivery systems |
CN110464977A (en) * | 2019-08-27 | 2019-11-19 | 郑州大学第一附属医院 | A kind of device using Platelet-rich plasm filling tissue sinus |
US11666771B2 (en) | 2020-05-29 | 2023-06-06 | AtaCor Medical, Inc. | Implantable electrical leads and associated delivery systems |
Family Cites Families (245)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE34866E (en) * | 1987-02-17 | 1995-02-21 | Kensey Nash Corporation | Device for sealing percutaneous puncture in a vessel |
US4744364A (en) | 1987-02-17 | 1988-05-17 | Intravascular Surgical Instruments, Inc. | Device for sealing percutaneous puncture in a vessel |
US4890612A (en) * | 1987-02-17 | 1990-01-02 | Kensey Nash Corporation | Device for sealing percutaneous puncture in a vessel |
US4852568A (en) | 1987-02-17 | 1989-08-01 | Kensey Nash Corporation | Method and apparatus for sealing an opening in tissue of a living being |
US4779611A (en) | 1987-02-24 | 1988-10-25 | Grooters Ronald K | Disposable surgical scope guide |
US4929246A (en) | 1988-10-27 | 1990-05-29 | C. R. Bard, Inc. | Method for closing and sealing an artery after removing a catheter |
US5620461A (en) * | 1989-05-29 | 1997-04-15 | Muijs Van De Moer; Wouter M. | Sealing device |
NL8901350A (en) * | 1989-05-29 | 1990-12-17 | Wouter Matthijs Muijs Van De M | CLOSURE ASSEMBLY. |
US6190400B1 (en) * | 1991-10-22 | 2001-02-20 | Kensey Nash Corporation | Blood vessel sealing device and method of sealing an opening in a blood vessel |
US6764500B1 (en) * | 1989-05-29 | 2004-07-20 | Kensey Nash Corporation | Sealing device |
US5104375A (en) * | 1989-10-16 | 1992-04-14 | Johnson & Johnson Medical, Inc. | Locking holder for a pair of syringes and method of use |
US5061274A (en) | 1989-12-04 | 1991-10-29 | Kensey Nash Corporation | Plug device for sealing openings and method of use |
JP2528602B2 (en) * | 1989-12-04 | 1996-08-28 | ケンゼー・ナッシュ・コーポレーション | Plug device for sealing the opening |
US5021059A (en) | 1990-05-07 | 1991-06-04 | Kensey Nash Corporation | Plug device with pulley for sealing punctures in tissue and methods of use |
US20080077178A1 (en) * | 1990-09-21 | 2008-03-27 | Datascope Investment Corp. | Device and method for sealing puncture wounds |
US7008439B1 (en) * | 1990-09-21 | 2006-03-07 | Datascope Investments Corp. | Device and method for sealing puncture wounds |
US5391183A (en) * | 1990-09-21 | 1995-02-21 | Datascope Investment Corp | Device and method sealing puncture wounds |
US5192300A (en) * | 1990-10-01 | 1993-03-09 | Quinton Instrument Company | Insertion assembly and method of inserting a vessel plug into the body of a patient |
US5108421A (en) * | 1990-10-01 | 1992-04-28 | Quinton Instrument Company | Insertion assembly and method of inserting a vessel plug into the body of a patient |
US5221259A (en) | 1990-12-27 | 1993-06-22 | Novoste Corporation | Wound treating device and method of using same |
US6325789B1 (en) | 1990-12-27 | 2001-12-04 | Datascope Investment Corporation | Device and method for sealing puncture wounds |
US5419765A (en) | 1990-12-27 | 1995-05-30 | Novoste Corporation | Wound treating device and method for treating wounds |
US5129882A (en) | 1990-12-27 | 1992-07-14 | Novoste Corporation | Wound clotting device and method of using same |
US5127393A (en) * | 1991-05-28 | 1992-07-07 | Medilase, Inc. | Flexible endoscope with rigid introducer |
CA2078530A1 (en) | 1991-09-23 | 1993-03-24 | Jay Erlebacher | Percutaneous arterial puncture seal device and insertion tool therefore |
US5290310A (en) | 1991-10-30 | 1994-03-01 | Howmedica, Inc. | Hemostatic implant introducer |
US5411520A (en) | 1991-11-08 | 1995-05-02 | Kensey Nash Corporation | Hemostatic vessel puncture closure system utilizing a plug located within the puncture tract spaced from the vessel, and method of use |
US5676689A (en) | 1991-11-08 | 1997-10-14 | Kensey Nash Corporation | Hemostatic puncture closure system including vessel location device and method of use |
US5222974A (en) | 1991-11-08 | 1993-06-29 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
US5282827A (en) | 1991-11-08 | 1994-02-01 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
US6699261B1 (en) | 1992-01-07 | 2004-03-02 | Cch Associates, Inc. | Blood vessel sealing system |
US6818008B1 (en) | 1992-01-07 | 2004-11-16 | Cch Associates, Inc. | Percutaneous puncture sealing method |
US6056768A (en) | 1992-01-07 | 2000-05-02 | Cates; Christopher U. | Blood vessel sealing system |
US6063085A (en) | 1992-04-23 | 2000-05-16 | Scimed Life Systems, Inc. | Apparatus and method for sealing vascular punctures |
US5810810A (en) | 1992-04-23 | 1998-09-22 | Scimed Life Systems, Inc. | Apparatus and method for sealing vascular punctures |
USRE40863E1 (en) | 1992-04-23 | 2009-07-21 | Boston Scientific Scimed, Inc. | Apparatus and method for sealing vascular punctures |
CA2134071C (en) * | 1992-04-23 | 1999-04-27 | Sew Wah Tay | Apparatus and method for sealing vascular punctures |
US6350274B1 (en) * | 1992-05-11 | 2002-02-26 | Regen Biologics, Inc. | Soft tissue closure systems |
US5326350A (en) | 1992-05-11 | 1994-07-05 | Li Shu Tung | Soft tissue closure systems |
US5413571A (en) | 1992-07-16 | 1995-05-09 | Sherwood Medical Company | Device for sealing hemostatic incisions |
US5443481A (en) | 1992-07-27 | 1995-08-22 | Lee; Benjamin I. | Methods and device for percutaneous sealing of arterial puncture sites |
US5342393A (en) | 1992-08-27 | 1994-08-30 | Duke University | Method and device for vascular repair |
US5415657A (en) | 1992-10-13 | 1995-05-16 | Taymor-Luria; Howard | Percutaneous vascular sealing method |
US5951583A (en) | 1993-05-25 | 1999-09-14 | Vascular Solutions, Inc. | Thrombin and collagen procoagulant and process for making the same |
US6017359A (en) * | 1993-05-25 | 2000-01-25 | Vascular Solutions, Inc. | Vascular sealing apparatus |
US5868778A (en) * | 1995-10-27 | 1999-02-09 | Vascular Solutions, Inc. | Vascular sealing apparatus and method |
US5383896A (en) * | 1993-05-25 | 1995-01-24 | Gershony; Gary | Vascular sealing device |
US5626601A (en) | 1995-10-27 | 1997-05-06 | Gary Gershony | Vascular sealing apparatus and method |
WO1994028800A1 (en) | 1993-06-04 | 1994-12-22 | Kensey Nash Corporation | Hemostatic vessel puncture closure with filament lock |
FR2707862B1 (en) | 1993-07-21 | 1995-10-13 | Nycomed Lab Sa | System for temporarily closing an orifice in a perforated organ, such as in particular a vessel. |
US5725551A (en) * | 1993-07-26 | 1998-03-10 | Myers; Gene | Method and apparatus for arteriotomy closure |
US5486195A (en) * | 1993-07-26 | 1996-01-23 | Myers; Gene | Method and apparatus for arteriotomy closure |
US5462561A (en) | 1993-08-05 | 1995-10-31 | Voda; Jan K. | Suture device |
US5354271A (en) * | 1993-08-05 | 1994-10-11 | Voda Jan K | Vascular sheath |
US5431639A (en) * | 1993-08-12 | 1995-07-11 | Boston Scientific Corporation | Treating wounds caused by medical procedures |
NL9301526A (en) | 1993-09-03 | 1995-04-03 | Cordis Europ | Device for hemostasis treatment after catheter surgery. |
US5843124A (en) | 1993-09-28 | 1998-12-01 | Hemodynamics, Inc. | Surface opening adhesive sealer |
US5653730A (en) | 1993-09-28 | 1997-08-05 | Hemodynamics, Inc. | Surface opening adhesive sealer |
US5383899A (en) * | 1993-09-28 | 1995-01-24 | Hammerslag; Julius G. | Method of using a surface opening adhesive sealer |
AT400675B (en) | 1993-10-18 | 1996-02-26 | Immuno Ag | SYRINGE SET FOR STORAGE AND APPLICATION OF A MULTI-COMPONENT MATERIAL, SYRINGE DEVICE AND ACTUATING DEVICE THEREFOR, AND METHOD FOR PRODUCING A FILLED, STERILE SYRINGE DEVICE |
US5370660A (en) * | 1993-11-01 | 1994-12-06 | Cordis Corporation | Apparatus and method for delivering a vessel plug into the body of a patient |
US5728122A (en) * | 1994-01-18 | 1998-03-17 | Datascope Investment Corp. | Guide wire with releaseable barb anchor |
US5531759A (en) * | 1994-04-29 | 1996-07-02 | Kensey Nash Corporation | System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating |
US20050065549A1 (en) * | 1997-09-12 | 2005-03-24 | Cates Christopher U. | Percutaneous puncture sealing system |
WO1995032671A1 (en) | 1994-06-01 | 1995-12-07 | Perclose, Inc. | Method and device for providing vascular hemostasis |
US6302898B1 (en) | 1994-06-24 | 2001-10-16 | Advanced Closure Systems, Inc. | Devices for sealing punctures in body vessels |
US20030109866A1 (en) | 1994-06-24 | 2003-06-12 | Neomend, Inc. | Vascular sealing device with microwave antenna |
US6033401A (en) * | 1997-03-12 | 2000-03-07 | Advanced Closure Systems, Inc. | Vascular sealing device with microwave antenna |
US5549633A (en) * | 1994-08-24 | 1996-08-27 | Kensey Nash Corporation | Apparatus and methods of use for preventing blood seepage at a percutaneous puncture site |
US5496332A (en) * | 1994-10-20 | 1996-03-05 | Cordis Corporation | Wound closure apparatus and method for its use |
US5649959A (en) | 1995-02-10 | 1997-07-22 | Sherwood Medical Company | Assembly for sealing a puncture in a vessel |
US5810846A (en) | 1995-08-03 | 1998-09-22 | United States Surgical Corporation | Vascular hole closure |
US6162192A (en) * | 1998-05-01 | 2000-12-19 | Sub Q, Inc. | System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge |
US5645566A (en) * | 1995-09-15 | 1997-07-08 | Sub Q Inc. | Apparatus and method for percutaneous sealing of blood vessel punctures |
US6071300A (en) * | 1995-09-15 | 2000-06-06 | Sub-Q Inc. | Apparatus and method for percutaneous sealing of blood vessel punctures |
US5674231A (en) | 1995-10-20 | 1997-10-07 | United States Surgical Corporation | Apparatus and method for vascular hole closure |
US6524326B1 (en) * | 1995-12-07 | 2003-02-25 | Loma Linda University Medical Center | Tissue opening locator and everter and method |
US6287322B1 (en) | 1995-12-07 | 2001-09-11 | Loma Linda University Medical Center | Tissue opening locator and everter and method |
US5728132A (en) * | 1996-04-08 | 1998-03-17 | Tricardia, L.L.C. | Self-sealing vascular access device |
US5728133A (en) | 1996-07-09 | 1998-03-17 | Cardiologics, L.L.C. | Anchoring device and method for sealing percutaneous punctures in vessels |
US5820631A (en) | 1996-08-01 | 1998-10-13 | Nr Medical, Inc. | Device and method for suturing tissue adjacent to a blood vessel |
US6063061A (en) | 1996-08-27 | 2000-05-16 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
US6066325A (en) | 1996-08-27 | 2000-05-23 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
US5810884A (en) | 1996-09-09 | 1998-09-22 | Beth Israel Deaconess Medical Center | Apparatus and method for closing a vascular perforation after percutaneous puncture of a blood vessel in a living subject |
US5728134A (en) * | 1996-09-17 | 1998-03-17 | Barak; Shlomo | Method and apparatus for hemostasis |
US6743248B2 (en) | 1996-12-18 | 2004-06-01 | Neomend, Inc. | Pretreatment method for enhancing tissue adhesion |
US6494848B1 (en) | 1996-12-19 | 2002-12-17 | St. Jude Medical Puerto Rico B.V. | Measuring device for use with a hemostatic puncture closure device |
US8323305B2 (en) | 1997-02-11 | 2012-12-04 | Cardiva Medical, Inc. | Expansile device for use in blood vessels and tracts in the body and method |
US6045570A (en) * | 1997-02-11 | 2000-04-04 | Biointerventional Corporation | Biological sealant mixture and system for use in percutaneous occlusion of puncture sites and tracts in the human body and method |
US6056769A (en) | 1997-02-11 | 2000-05-02 | Biointerventional Corporation | Expansile device for use in blood vessels and tracts in the body and tension application device for use therewith and method |
US5951589A (en) | 1997-02-11 | 1999-09-14 | Biointerventional Corporation | Expansile device for use in blood vessels and tracts in the body and tension application device for use therewith and method |
US6464712B1 (en) | 1997-02-11 | 2002-10-15 | Biointerventional Corporation | Expansile device for use in blood vessels and tracts in the body and method |
US5782860A (en) | 1997-02-11 | 1998-07-21 | Biointerventional Corporation | Closure device for percutaneous occlusion of puncture sites and tracts in the human body and method |
US6371975B2 (en) * | 1998-11-06 | 2002-04-16 | Neomend, Inc. | Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers |
US20040176801A1 (en) * | 1997-03-12 | 2004-09-09 | Neomend, Inc. | Pretreatment method for enhancing tissue adhesion |
US20030191496A1 (en) | 1997-03-12 | 2003-10-09 | Neomend, Inc. | Vascular sealing device with microwave antenna |
US6733515B1 (en) | 1997-03-12 | 2004-05-11 | Neomend, Inc. | Universal introducer |
US5984948A (en) | 1997-04-14 | 1999-11-16 | Hasson; Harrith M. | Device for closing an opening in tissue and method of closing a tissue opening using the device |
US5830232A (en) | 1997-04-14 | 1998-11-03 | Hasson; Harrith M. | Device for closing an opening in tissue and method of closing a tissue opening using the device |
JPH10295699A (en) * | 1997-04-24 | 1998-11-10 | Clinical Supply:Kk | Hemostasis implement |
EP0895753A1 (en) | 1997-07-31 | 1999-02-10 | Academisch Ziekenhuis Utrecht | Temporary vascular seal for anastomosis |
US5906631A (en) | 1997-12-05 | 1999-05-25 | Surface Genesis, Inc. | Method and device for sealing vascular puncture wounds |
US6478808B2 (en) * | 1997-12-17 | 2002-11-12 | Closys Corporation | Clotting cascade initiating apparatus and methods of use and methods of closing wounds |
US6159232A (en) | 1997-12-16 | 2000-12-12 | Closys Corporation | Clotting cascade initiating apparatus and methods of use and methods of closing wounds |
CA2320956A1 (en) | 1998-02-13 | 1999-08-19 | Ventrica, Inc. | Methods and devices providing transmyocardial blood flow to the arterial vascular system of the heart |
US6315753B1 (en) | 1998-05-01 | 2001-11-13 | Sub-Q, Inc. | System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge |
US6610026B2 (en) | 1998-05-01 | 2003-08-26 | Sub-Q, Inc. | Method of hydrating a sponge material for delivery to a body |
US7625352B1 (en) | 1998-05-01 | 2009-12-01 | Sub-Q, Inc. | Depth and puncture control for system for hemostasis of blood vessel |
US5910155A (en) | 1998-06-05 | 1999-06-08 | United States Surgical Corporation | Vascular wound closure system |
US6048357A (en) * | 1998-07-09 | 2000-04-11 | X-Site, L.L.C. | Anchoring device and method for sealing punctures in vessels |
US6048358A (en) * | 1998-07-13 | 2000-04-11 | Barak; Shlomo | Method and apparatus for hemostasis following arterial catheterization |
US6669707B1 (en) | 1998-07-21 | 2003-12-30 | Lee L. Swanstrom | Method and apparatus for attaching or locking an implant to an anatomic vessel or hollow organ wall |
US6334865B1 (en) * | 1998-08-04 | 2002-01-01 | Fusion Medical Technologies, Inc. | Percutaneous tissue track closure assembly and method |
WO2000007505A1 (en) * | 1998-08-04 | 2000-02-17 | Fusion Medical Technologies, Inc. | Percutaneous tissue track closure assembly and method |
US6613070B2 (en) | 1998-08-04 | 2003-09-02 | Baxter International Inc. | System and method for sealing vascular penetrations with hemostatic gels |
US6152943A (en) | 1998-08-14 | 2000-11-28 | Incept Llc | Methods and apparatus for intraluminal deposition of hydrogels |
US7790192B2 (en) | 1998-08-14 | 2010-09-07 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
AU759991B2 (en) * | 1998-08-26 | 2003-05-01 | Neo Mend, Inc. | Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers or covering structures |
US6458147B1 (en) | 1998-11-06 | 2002-10-01 | Neomend, Inc. | Compositions, systems, and methods for arresting or controlling bleeding or fluid leakage in body tissue |
US6994686B2 (en) | 1998-08-26 | 2006-02-07 | Neomend, Inc. | Systems for applying cross-linked mechanical barriers |
US6022361A (en) * | 1998-10-09 | 2000-02-08 | Biointerventional Corporation | Device for introducing and polymerizing polymeric biomaterials in the human body and method |
US6949114B2 (en) | 1998-11-06 | 2005-09-27 | Neomend, Inc. | Systems, methods, and compositions for achieving closure of vascular puncture sites |
US8802146B2 (en) | 1998-11-06 | 2014-08-12 | Neomend, Inc. | Systems, methods, and compositions for prevention of tissue adhesion |
US6899889B1 (en) | 1998-11-06 | 2005-05-31 | Neomend, Inc. | Biocompatible material composition adaptable to diverse therapeutic indications |
US6830756B2 (en) | 1998-11-06 | 2004-12-14 | Neomend, Inc. | Systems, methods, and compositions for achieving closure of vascular puncture sites |
US7279001B2 (en) | 1998-11-06 | 2007-10-09 | Neomend, Inc. | Systems, methods, and compositions for achieving closure of vascular puncture sites |
US7351249B2 (en) | 1998-11-06 | 2008-04-01 | Neomend, Inc. | Systems, methods, and compositions for achieving closure of suture sites |
CA2317661C (en) | 1998-11-20 | 2008-04-15 | Medical Industries Corp. | Hemostatic material insertion device |
US6080183A (en) | 1998-11-24 | 2000-06-27 | Embol-X, Inc. | Sutureless vessel plug and methods of use |
US20030069601A1 (en) * | 1998-12-15 | 2003-04-10 | Closys Corporation | Clotting cascade initiating apparatus and methods of use |
US6146372A (en) | 1998-12-24 | 2000-11-14 | Datascope Investment Corp | Apparatus and method for the percutaneous insertion of a pediatric intra-aortic balloon catheter |
US6126675A (en) | 1999-01-11 | 2000-10-03 | Ethicon, Inc. | Bioabsorbable device and method for sealing vascular punctures |
US6120524A (en) | 1999-02-16 | 2000-09-19 | Taheri; Syde A. | Device for closing an arterial puncture and method |
US6537299B1 (en) * | 1999-04-05 | 2003-03-25 | Ethicon, Inc. | Intravascular hemostasis device and method |
US6328757B1 (en) | 1999-04-23 | 2001-12-11 | Robert G. Matheny | Device and method for performing surgery without impeding organ function |
US6482179B1 (en) | 1999-05-28 | 2002-11-19 | Cohesion Technologies, Inc. | Apparatuses, methods and compositions for closing tissue puncture openings |
WO2000074575A1 (en) | 1999-06-01 | 2000-12-14 | Closys Corporation | Clotting cascade initiating apparatus and methods of use |
US6206895B1 (en) * | 1999-07-13 | 2001-03-27 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
US6984219B2 (en) * | 1999-09-23 | 2006-01-10 | Mark Ashby | Depth and puncture control for blood vessel hemostasis system |
US6942674B2 (en) | 2000-01-05 | 2005-09-13 | Integrated Vascular Systems, Inc. | Apparatus and methods for delivering a closure device |
US7842068B2 (en) | 2000-12-07 | 2010-11-30 | Integrated Vascular Systems, Inc. | Apparatus and methods for providing tactile feedback while delivering a closure device |
US6197042B1 (en) | 2000-01-05 | 2001-03-06 | Medical Technology Group, Inc. | Vascular sheath with puncture site closure apparatus and methods of use |
US6780197B2 (en) | 2000-01-05 | 2004-08-24 | Integrated Vascular Systems, Inc. | Apparatus and methods for delivering a vascular closure device to a body lumen |
AU778318B2 (en) | 2000-02-03 | 2004-11-25 | Tissuemed Limited | Device for the closure of a surgical puncture |
US6547806B1 (en) | 2000-02-04 | 2003-04-15 | Ni Ding | Vascular sealing device and method of use |
US6540735B1 (en) * | 2000-05-12 | 2003-04-01 | Sub-Q, Inc. | System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge |
US6846321B2 (en) * | 2000-06-21 | 2005-01-25 | Cardiodex, Ltd. | Mechanical method and apparatus for enhancing hemostatis following arterial catheterization |
AU2001273401A1 (en) | 2000-07-14 | 2002-01-30 | Sub-Q Inc. | Sheath-mounted arterial plug delivery device |
US6890342B2 (en) | 2000-08-02 | 2005-05-10 | Loma Linda University | Method and apparatus for closing vascular puncture using hemostatic material |
US6695867B2 (en) | 2002-02-21 | 2004-02-24 | Integrated Vascular Systems, Inc. | Plunger apparatus and methods for delivering a closure device |
US6623510B2 (en) * | 2000-12-07 | 2003-09-23 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US6623509B2 (en) | 2000-12-14 | 2003-09-23 | Core Medical, Inc. | Apparatus and methods for sealing vascular punctures |
US6969397B2 (en) | 2000-12-14 | 2005-11-29 | Ensure Medical, Inc. | Guide wire element for positioning vascular closure devices and methods for use |
US6846319B2 (en) | 2000-12-14 | 2005-01-25 | Core Medical, Inc. | Devices for sealing openings through tissue and apparatus and methods for delivering them |
DE60205780T2 (en) | 2001-01-12 | 2006-05-18 | Radi Medical Systems Ab | Arterial wall occlusion device provided with a position indicator |
US6569185B2 (en) | 2001-02-15 | 2003-05-27 | Scimed Life Systems Inc | Continuous infusion technique for arterial sealing |
US6743195B2 (en) | 2001-03-14 | 2004-06-01 | Cardiodex | Balloon method and apparatus for vascular closure following arterial catheterization |
JP4267867B2 (en) * | 2001-05-03 | 2009-05-27 | ラディ・メディカル・システムズ・アクチェボラーグ | Wound occlusion element guide device |
ES2223679T3 (en) | 2001-05-09 | 2005-03-01 | Radi Medical Systems Ab | SHUTTER OF AN ARTERIAL PERFORATION. |
US7029489B1 (en) | 2001-05-18 | 2006-04-18 | Sub-Q, Inc. | System and method for delivering hemostasis promoting material to a blood vessel puncture site |
US6863680B2 (en) * | 2001-11-08 | 2005-03-08 | Sub-Q, Inc. | System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure |
US7008440B2 (en) * | 2001-11-08 | 2006-03-07 | Sub-Q, Inc. | System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure |
AU2002310364B2 (en) | 2001-06-08 | 2006-02-23 | Morris Innovative Research, Inc. | Method and apparatus for sealing access |
US20060004408A1 (en) * | 2001-06-08 | 2006-01-05 | Morris Edward J | Method and apparatus for sealing access |
JP4159805B2 (en) | 2001-06-15 | 2008-10-01 | ラディ・メディカル・システムズ・アクチェボラーグ | Pushing mechanism for closing method |
JP4180509B2 (en) * | 2001-07-26 | 2008-11-12 | ウイルソンークック メディカル インク. | Vessel occlusion member and distribution device thereof |
US6592608B2 (en) | 2001-12-07 | 2003-07-15 | Biopsy Sciences, Llc | Bioabsorbable sealant |
SE523902C2 (en) * | 2001-09-07 | 2004-06-01 | Jan Otto Solem | Apparatus for closing a puncture in a body vessel |
US7025748B2 (en) | 2001-11-08 | 2006-04-11 | Boston Scientific Scimed, Inc. | Sheath based blood vessel puncture locator and depth indicator |
US7192436B2 (en) * | 2001-11-08 | 2007-03-20 | Sub-Q, Inc. | Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure |
US20030109820A1 (en) | 2001-12-07 | 2003-06-12 | Gross T. Daniel | Hemostatic agent delivery system |
US6814743B2 (en) | 2001-12-26 | 2004-11-09 | Origin Medsystems, Inc. | Temporary seal and method for facilitating anastomosis |
US20040093027A1 (en) | 2002-03-04 | 2004-05-13 | Walter Fabisiak | Barbed tissue connector for sealing vascular puncture wounds |
US6936033B2 (en) | 2002-06-14 | 2005-08-30 | Medtronic, Inc. | Multiple ratio fluid dispenser |
US6939363B2 (en) | 2002-06-12 | 2005-09-06 | Radi Medical Systems Ab | Closure device |
US8308758B2 (en) * | 2002-06-12 | 2012-11-13 | Radi Medical Systems Ab | Closure device |
US7135027B2 (en) | 2002-10-04 | 2006-11-14 | Baxter International, Inc. | Devices and methods for mixing and extruding medically useful compositions |
US6849061B2 (en) * | 2002-10-21 | 2005-02-01 | Robert B. Wagner | Method and apparatus for pleural drainage |
US8398675B2 (en) | 2002-10-25 | 2013-03-19 | Radi Medical Systems Ab | Absorbable medical sealing device with retaining assembly having at least two loops |
US8709038B2 (en) | 2002-12-20 | 2014-04-29 | Boston Scientific Scimed, Inc. | Puncture hole sealing device |
US7008442B2 (en) * | 2003-01-20 | 2006-03-07 | Medtronic Vascular, Inc. | Vascular sealant delivery device and sheath introducer and method |
US7223266B2 (en) | 2003-02-04 | 2007-05-29 | Cardiodex Ltd. | Methods and apparatus for hemostasis following arterial catheterization |
US8262671B2 (en) | 2003-03-14 | 2012-09-11 | Oscor Inc. | Vascular introducer having hemostatic valve with integral seal |
US7488340B2 (en) * | 2003-06-02 | 2009-02-10 | Vascular Solutions, Inc. | Vascular access closure system |
US7331979B2 (en) * | 2003-06-04 | 2008-02-19 | Access Closure, Inc. | Apparatus and methods for sealing a vascular puncture |
US9289195B2 (en) | 2003-06-04 | 2016-03-22 | Access Closure, Inc. | Auto-retraction apparatus and methods for sealing a vascular puncture |
CA2535452C (en) | 2003-08-14 | 2013-04-02 | Loma Linda University Medical Center | Vascular wound closure device |
US20050085853A1 (en) * | 2003-10-15 | 2005-04-21 | Forsberg Andrew T. | Collagen delivery assembly with blood perfusion holes |
US8337522B2 (en) * | 2003-10-15 | 2012-12-25 | St. Jude Medical Puerto Rico Llc | Vascular sealing device with locking hub |
US7931670B2 (en) * | 2003-10-15 | 2011-04-26 | St. Jude Medical Puerto Rico Llc | Tissue puncture closure device with automatic tamping |
US7361183B2 (en) | 2003-10-17 | 2008-04-22 | Ensure Medical, Inc. | Locator and delivery device and method of use |
US8852229B2 (en) | 2003-10-17 | 2014-10-07 | Cordis Corporation | Locator and closure device and method of use |
WO2005051176A2 (en) | 2003-11-25 | 2005-06-09 | Boston Scientific Limited | Hemostatic pressure plug |
US7597705B2 (en) | 2003-12-03 | 2009-10-06 | St. Jude Medical Puerto Rico Llc | Vascular puncture seal anchor nest |
US20050149117A1 (en) | 2003-12-24 | 2005-07-07 | Farhad Khosravi | Apparatus and methods for delivering sealing materials during a percutaneous procedure to facilitate hemostasis |
US20050245876A1 (en) | 2003-12-24 | 2005-11-03 | Accessclosure, Inc. | Apparatus and methods for facilitating access through a puncture including sealing compound therein |
US20080154303A1 (en) | 2006-12-21 | 2008-06-26 | Cardiva Medical, Inc. | Hemostasis-enhancing device and method for its use |
US7572274B2 (en) | 2004-05-27 | 2009-08-11 | Cardiva Medical, Inc. | Self-tensioning vascular occlusion device and method for its use |
US7993366B2 (en) | 2004-05-27 | 2011-08-09 | Cardiva Medical, Inc. | Self-tensioning vascular occlusion device and method for its use |
US7766891B2 (en) * | 2004-07-08 | 2010-08-03 | Pneumrx, Inc. | Lung device with sealing features |
US8348971B2 (en) * | 2004-08-27 | 2013-01-08 | Accessclosure, Inc. | Apparatus and methods for facilitating hemostasis within a vascular puncture |
US8262693B2 (en) | 2004-11-05 | 2012-09-11 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
JP2006141436A (en) * | 2004-11-16 | 2006-06-08 | Mebiol Kk | Percutaneous vascular puncture sealing material and percutaneous vascular puncture sealing apparatus |
WO2006074044A2 (en) | 2004-12-30 | 2006-07-13 | Neomend, Inc. | Method and apparatus for percutaneous wound sealing |
US7344544B2 (en) * | 2005-03-28 | 2008-03-18 | Cardica, Inc. | Vascular closure system |
US20060229670A1 (en) | 2005-04-01 | 2006-10-12 | Bates Brian L | Method and a medical closure system for sealing a puncture |
US7988706B2 (en) | 2005-04-11 | 2011-08-02 | St. Jude Medical Puerto Rico Llc | Tissue puncture closure device with automatic torque sensing tamping system |
US7250057B2 (en) | 2005-04-11 | 2007-07-31 | St. Jude Medical Puerto Rico B.V. | Tissue puncture closure device with automatic torque sensing tamping system |
US7618436B2 (en) | 2005-04-12 | 2009-11-17 | St. Jude Medical Puerto Rico Llc | Tissue puncture closure device with scroll gear transmission tamping system |
EP3199110A1 (en) * | 2005-04-22 | 2017-08-02 | Access Closure, Inc. | Apparatus and method for sealing a puncture in tissue |
US8002742B2 (en) | 2005-04-22 | 2011-08-23 | Accessclosure, Inc. | Apparatus and methods for sealing a puncture in tissue |
US7806856B2 (en) * | 2005-04-22 | 2010-10-05 | Accessclosure, Inc. | Apparatus and method for temporary hemostasis |
US8926654B2 (en) | 2005-05-04 | 2015-01-06 | Cordis Corporation | Locator and closure device and method of use |
US20060276838A1 (en) | 2005-06-07 | 2006-12-07 | Wensel Jeffrey P | Vascular puncture sealing method, apparatus, and system |
US20060276840A1 (en) | 2005-05-09 | 2006-12-07 | Yakov Perper | Methods and devices for treating dural puncture |
US7618438B2 (en) * | 2005-05-17 | 2009-11-17 | St. Jude Medical Puerto Rico Llc | Tissue puncture closure device with disengagable automatic tamping system |
US20070032824A1 (en) * | 2005-08-04 | 2007-02-08 | St. Jude Medical Puerto Rico B.V. | Tissue puncture closure device with track plug |
US7691127B2 (en) | 2005-12-13 | 2010-04-06 | Cardiva Medical, Inc. | Drug eluting vascular closure devices and methods |
US9179897B2 (en) | 2005-12-13 | 2015-11-10 | Cardiva Medical, Inc. | Vascular closure devices and methods providing hemostatic enhancement |
US9427216B2 (en) | 2005-12-23 | 2016-08-30 | CARDINAL HEALTH SWITZERLAND 515 GmbH | Systems and methods for closing a vessel wound |
US8382794B2 (en) * | 2006-01-04 | 2013-02-26 | St. Jude Medical Puerto Rico Llc | Balloon insertion apparatus and method of sealing a tissue puncture |
US7850710B2 (en) | 2006-05-23 | 2010-12-14 | St. Jude Medical Puerto Rico Llc | Puncture closure apparatuses, sealing plugs, and related methods |
US7789893B2 (en) * | 2006-09-12 | 2010-09-07 | Boston Scientific Scimed, Inc. | Method and apparatus for promoting hemostasis of a blood vessel puncture |
US8617204B2 (en) | 2006-09-13 | 2013-12-31 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
US8430906B2 (en) | 2006-09-29 | 2013-04-30 | St. Jude Medical, Cardiology Division, Inc. | Method and apparatus to promote hemostasis |
US7552853B2 (en) | 2007-01-24 | 2009-06-30 | Medtronic Vascular, Inc. | Low-profile vascular closure systems and methods of using same |
EP2117423A4 (en) | 2007-01-26 | 2011-11-09 | Endotronix Inc | Vascular closure device having sensor |
US8721679B2 (en) | 2007-02-05 | 2014-05-13 | Boston Scientific Scimed, Inc. | Apparatus and method for closing an opening in a blood vessel using a permanent implant |
US9427217B2 (en) | 2007-02-05 | 2016-08-30 | Boston Scientific Scimed Inc. | Apparatus and method for closing an opening in a blood vessel using memory metal and collagen |
US8226681B2 (en) | 2007-06-25 | 2012-07-24 | Abbott Laboratories | Methods, devices, and apparatus for managing access through tissue |
US8366706B2 (en) | 2007-08-15 | 2013-02-05 | Cardiodex, Ltd. | Systems and methods for puncture closure |
US8568445B2 (en) * | 2007-08-21 | 2013-10-29 | St. Jude Medical Puerto Rico Llc | Extra-vascular sealing device and method |
US7771455B2 (en) * | 2007-08-31 | 2010-08-10 | Ken Christopher G M | Closure medical device |
US20090082802A1 (en) * | 2007-09-26 | 2009-03-26 | Medtronic Vascular, Inc. | Mechanism and Method for Closing an Arteriotomy |
US7993367B2 (en) | 2007-09-28 | 2011-08-09 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
US7875054B2 (en) | 2007-10-01 | 2011-01-25 | Boston Scientific Scimed, Inc. | Connective tissue closure device and method |
WO2009058999A2 (en) | 2007-10-31 | 2009-05-07 | Texas Heart Institute | Method and apparatus for vascular access |
US8858591B2 (en) | 2007-10-31 | 2014-10-14 | Radi Medical Systems Ab | Method and device for sealing a puncture hole in a bodily organ |
US8652166B2 (en) | 2007-11-30 | 2014-02-18 | Radi Medical Systems Ab | Insertion tool for a medical closure device |
US20090143815A1 (en) | 2007-11-30 | 2009-06-04 | Boston Scientific Scimed, Inc. | Apparatus and Method for Sealing a Vessel Puncture Opening |
US8840640B2 (en) | 2007-12-31 | 2014-09-23 | St. Jude Medical Puerto Rico Llc | Vascular closure device having an improved plug |
US20090216267A1 (en) | 2008-02-26 | 2009-08-27 | Boston Scientific Scimed, Inc. | Closure device with rapidly dissolving anchor |
US8241324B2 (en) | 2008-03-03 | 2012-08-14 | Eilaz Babaev | Ultrasonic vascular closure device |
CA2820450C (en) | 2008-03-14 | 2017-04-11 | Cordis Corporation | Vascular closure device |
US8029533B2 (en) | 2008-04-04 | 2011-10-04 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
-
2009
- 2009-08-20 WO PCT/US2009/054492 patent/WO2010027693A2/en active Application Filing
- 2009-08-20 CA CA2734269A patent/CA2734269A1/en not_active Abandoned
- 2009-08-20 AU AU2009288440A patent/AU2009288440B2/en not_active Ceased
- 2009-08-20 EP EP11192667.1A patent/EP2430982B1/en active Active
- 2009-08-20 EP EP09791741.3A patent/EP2330981B1/en active Active
- 2009-08-20 JP JP2011525104A patent/JP5616891B2/en not_active Expired - Fee Related
- 2009-08-24 US US12/461,775 patent/US8506592B2/en active Active
-
2011
- 2011-02-25 CR CR20110105A patent/CR20110105A/en not_active Application Discontinuation
-
2013
- 2013-08-12 US US13/964,989 patent/US8845683B2/en active Active
Non-Patent Citations (1)
Title |
---|
None |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9610070B2 (en) | 2007-06-15 | 2017-04-04 | Vivasure Medical Limited | Closure device |
US11357486B2 (en) | 2009-12-30 | 2022-06-14 | Vivasure Medical Limited | Closure system and uses thereof |
US9060751B2 (en) | 2010-12-30 | 2015-06-23 | Vivasure Medical Limited | Surgical closure systems and methods |
WO2012148745A1 (en) * | 2011-04-25 | 2012-11-01 | St. Jude Medical Puerto Rico Llc | Distal balloon bond for temporary sealing location device and methods |
US9480468B2 (en) | 2011-04-25 | 2016-11-01 | St. Jude Medical Puerto Rico Llc | Distal balloon bond for temporary sealing location device and methods |
WO2013128292A3 (en) * | 2012-02-29 | 2014-03-06 | Vivasure Medical Limited | Percutaneous perforation closure systems, devices, and methods |
US10966698B2 (en) | 2012-02-29 | 2021-04-06 | Vivasure Medical Limited | Implants and methods for percutaneous perforation closure |
US9737286B2 (en) | 2012-02-29 | 2017-08-22 | Vivasure Medical Limited | Implants and methods for percutaneous perforation closure |
US9572558B2 (en) | 2012-02-29 | 2017-02-21 | Vivasure Medical Limited | Devices and methods for delivering implants for percutaneous perforation closure |
US9662099B2 (en) | 2012-02-29 | 2017-05-30 | Vivasure Medical Limited | Percutaneous perforation closure systems, devices, and methods |
EP3653136A1 (en) * | 2013-01-03 | 2020-05-20 | JustRight Surgical, LLC | Medical device for use in laparoscopic surgery |
WO2014107393A1 (en) | 2013-01-03 | 2014-07-10 | Just Right Surgical, Llc | Medical device and method of use |
EP2925244A4 (en) * | 2013-01-03 | 2017-02-22 | Just Right Surgical, LLC | Medical device and method of use |
US10806446B2 (en) | 2013-01-03 | 2020-10-20 | Bolder Surgical, Llc | Device for use in laparoscopic surgery and method of use |
US9750497B2 (en) | 2013-01-03 | 2017-09-05 | Just Right Surgical, Llc | Device for use in laparoscopic surgery and method of use |
WO2014130106A1 (en) * | 2013-02-21 | 2014-08-28 | St. Jude Medical Puerto Rico Llc | Detachable sealing plug with safety release mechanism and methods |
US9241694B2 (en) | 2013-02-21 | 2016-01-26 | St. Jude Medical Puerto Rico Llc | Bioadhesive delivery systems and methods for vascular closure |
WO2014130107A1 (en) * | 2013-02-21 | 2014-08-28 | St. Jude Medical Puerto Rico Llc | Bioadhesive delivery system and methods for vascular closure |
US9597065B2 (en) | 2013-02-21 | 2017-03-21 | St. Jude Medical Puerto Rico Llc | Detachable sealing plug with safety release mechanism and methods |
US9850013B2 (en) | 2013-03-15 | 2017-12-26 | Vivasure Medical Limited | Loading devices and methods for percutaneous perforation closure systems |
US10206668B2 (en) | 2014-12-15 | 2019-02-19 | Vivasure Medical Limited | Implantable sealable member with mesh layer |
US10433826B2 (en) | 2014-12-15 | 2019-10-08 | Vivasure Medical Limited | Closure apparatus with flexible sealable member and flexible support member |
US11141142B2 (en) | 2014-12-15 | 2021-10-12 | Vivasure Medical Limited | Implantable sealable member with mesh layer |
US11478235B2 (en) | 2014-12-15 | 2022-10-25 | Vivasure Medical Limited | Closure apparatus with flexible sealable member and flexible support member |
US11311280B2 (en) | 2015-12-15 | 2022-04-26 | Vivasure Medical Limited | Arteriotomy closure apparatus with slotted shoe for advantageous pressure distribution |
US11653921B2 (en) | 2020-05-04 | 2023-05-23 | Bolder Surgical, Llc | Anti-buckling actuation members for a surgical instrument |
US11957328B2 (en) | 2021-02-26 | 2024-04-16 | Vivasure Medical Limited | Implants and methods for percutaneous perforation closure |
Also Published As
Publication number | Publication date |
---|---|
AU2009288440A1 (en) | 2010-03-11 |
WO2010027693A8 (en) | 2010-07-01 |
EP2330981A2 (en) | 2011-06-15 |
US20130338707A1 (en) | 2013-12-19 |
US8506592B2 (en) | 2013-08-13 |
CA2734269A1 (en) | 2010-03-11 |
US20100211000A1 (en) | 2010-08-19 |
JP5616891B2 (en) | 2014-10-29 |
AU2009288440B2 (en) | 2015-04-23 |
US8845683B2 (en) | 2014-09-30 |
EP2430982A3 (en) | 2012-05-16 |
WO2010027693A4 (en) | 2010-08-19 |
EP2330981B1 (en) | 2013-11-27 |
EP2430982B1 (en) | 2020-06-24 |
JP2012501220A (en) | 2012-01-19 |
EP2430982A2 (en) | 2012-03-21 |
CR20110105A (en) | 2011-10-24 |
WO2010027693A3 (en) | 2010-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8845683B2 (en) | Method and system for sealing percutaneous punctures | |
US11707265B2 (en) | Apparatus and methods for sealing a vascular puncture | |
US11534150B2 (en) | Apparatus and methods for sealing a vascular puncture | |
US7789893B2 (en) | Method and apparatus for promoting hemostasis of a blood vessel puncture | |
JP5940622B2 (en) | Method and system for sealing a percutaneous puncture site | |
US7993367B2 (en) | Apparatus and methods for sealing a vascular puncture | |
US20050245876A1 (en) | Apparatus and methods for facilitating access through a puncture including sealing compound therein | |
US11925337B2 (en) | Apparatus and methods for sealing a vascular puncture | |
EP1513456A1 (en) | Vascular wound closure device and method | |
KR20170083040A (en) | Apparatus and method for sealing a vascular puncture | |
US20120330352A1 (en) | Transapical closure devices and methods for use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09791741 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009791741 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2734269 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2011525104 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: CR2011-000105 Country of ref document: CR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009288440 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2009288440 Country of ref document: AU Date of ref document: 20090820 Kind code of ref document: A |